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This thesis describes capillary electrophoresis (CE) methods for separation and quantification 
of cyanotoxins in water; and “metabolomic” and “metabonomic” approaches for investigation 
of the effect of exposure of a human cell line to low amounts of microcystins. 
Incidences of toxic algal blooms in water bodies have increased. Toxic algae releases toxins 
into water bodies which puts water consumers at risk of exposure. Exposure to algal toxins is 
associated with harmful effects such as hepatotoxicity. Humans are at risk of non obvious 
exposure leading to chronic exposure to cyanobacterial toxins because contamination may 
not be visible to the naked eye. It is therefore important to develop analytical techniques 
which can adequately detect and quantify these toxins; moreover the effect of exposure to 
low amounts of microcystins in human has not been reported.  
Capillary zone electrophoresis (CZE), micellar electrokinetic capillary electrophoresis 
(MEKC) and microemulsion electrokinetic chromatography (MEEC) were developed to 
determine microcystins LA, LF, LR, LW, RR, YR, nodularin (related hepatotoxin) and 
cylindrospermopsin, a hepatotoxic alkaloid. The CE methods were validated for use on a 
portable capillary electrophoresis instrument.   Solid phase extraction (SPE) enabled cleanup 
and pre-concentration of a real sample and detection limits after SPE of the real sample 
spiked with microcystins were 0.90 g/L (RR), 0.76 g/L (YR), and 1.10 g/L (LR), with 
relative standard deviation (% RSD) values of 9.9-11.7 % for peak area and 2.2-3.3 % for 
migration time respectively. SPE recoveries were 90.3 % (RR), 101.5 % (nodularin), 90.6 % 
(YR), and 88.2 % (LR). In MEEC, online pre-concentration with the aid of a solvent plug 
achieved a 2-10 fold increase in peak area and height and the detection limit was in the range 
of 0.15-3 µg/ mL.  Freeze drying together with sample stacking was used to achieve detection 
limits of 0.2-1.1 g/L. These methods can be used for routine water analysis to monitor 
ix 
 
microcystins up to concentrations limits as set by the World Health Organisation (WHO) 
drinking water guidelines.         
 In the investigation of microcystin toxicity, HepG2 cells were incubated in media spiked 
with microcystins LR, RR, YR or a mixture of the three microcystins at different 
concentrations. Then aliquots of the media were sampled at specific time intervals, extracted 
and analysed using one dimensional proton nuclear magnetic resonance (
1
H NMR) and direct 
injection mass spectrometry (DIMS). Data obtained was reduced by principal component 
analysis (PCA) using SIMCA P
+ software. The use of PCA and “metabolic finger/foot 
printing” techniques, allowed a distinction between samples exposed to microcystins, those 
exposed to acetaminophen (positive control), and those that were not exposed (negative 
control samples).  
 
Components responsible for the differences in patterns observed on the PCA plots were 
profiled and several metabolites were identified.  Generally exposure to microcystins in the 
range of 1 ng/mL to 100 ng/mL interfered with the metabolisms of carbohydrates, amino 
acids, organic acids and lipids. The effects were more severe as concentration increased and 
more prominent for microcystin LR compared to microcystins RR and YR. The 
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1
HNMR  One dimensional proton nuclear magnetic resonance 
Adda    2S, 3S, 8S, 9S-3-amino-9-methoxy-2, 6, 8-trimethyl-10-phenyldeca-4, 6-dienoic acid 
BGE   Background electrolyte 
C4D   Capacitively coupled contactless conductivity detector 
CAPS   N-cyclohexyl-3-aminopropanesulfonic acid 
CE   Capillary Electrophoresis 
CSEI   Cation selective exhaustive injection 
CZE    Capillary zone electrophoresis 
DAG   Diacylglycerol 
DIMS   Direct injection mass spectrometry 
HPLC   High performance liquid chromatography 
Id   Internal diameter 
ITP   Isotachophoresis 
LC   Liquid chromatography 
MAPK   Microtubule-associated protein kinase 
MEEKC/MEEC Microemulsion electro chromatography 
MEKC/MECC  Micellar electrochromatography 
MS   Mass spectrometry 
OATP   Organic anion transport peptide 
P53    Protein 53 (tumor protein 53) 
PI    Propidium iodide 
PKC   Protein kinase C 
PP1   Protein phosphatase 1 
PP2A   Protein phosphatase 2 A 
ROS   Reactive oxygen species 
SDS   Sodium dodecyl sulphate 
SPE   Solid phase extraction 
TCA   Tricarboxylic acid  
TO   Thiazole orange 
UV   Ultra violet 




Presence of algae in our water bodies is a public health concern because algae not only 
affects the water aesthetically but also contains harmful toxins commonly referred to as 
cyanotoxins (microcystins and others). According to the world health organisation (WHO) 
drinking water guideline
1
 the limit for microcystins in water is 1g/L microcystin LR or its 
equivalents. The increased occurrence of algal blooms in water bodies has increased the 
presence of toxic algae which increases the likely hood of exposure of animals and humans to 
algal toxins. Since the toxins are harmful they need to be continuously monitored in our water 
sources using analytical techniques.   In this study, capillary electrophoresis techniques were 
developed for the determination of cyanobacterial toxins (including microcystins, nodularin 
and cylindrospermopsin) in water and potential effects of exposure to microcystins were 
investigated. The effect of exposure of a human cell line to low amounts of microcystins was 
studied using HepG2 cell line by “metabolomic” and “metabonomic” approaches. 
Metabolites were profiled and pattern recognition tools were used to identify differences 
among the metabolite quantities due to exposure to microcystins. Algal toxins are explained 
in detail in the following section. 
 
 
1.1.   Algal Toxins 
 
Algae are a diverse kind of life and play an important role in the ecology of rivers and 
estuaries. Algae range from single-celled microscopic plants to multi-cellular plants and have 
2 
 
different colours and shapes. Algae are widely distributed but the biggest percentage is found 
in the waters which cover 70 per cent of the earth’s surface. Microscopic algae (microalgae) 
are a major component of plankton therefore they form the basis of aquatic food chains. They 
include diatoms, dinoflagellates, chlorophytes and cyanobacteria. Algae produce oxygen and 
are the primary producers of organic carbon in water bodies, are food for aquatic life such as 
fish and mussels as well as other animals like birds. The larger algae (macroalgae) are useful 
as a habitat for water dwelling organisms, provide shelter from predators and reduce soil 




Increased intensity and frequency of algal blooms 
3, 4, 5
 is of concern, because algae interfere 
with the natural balance of plant and animal ecosystems in a water body 
2
. Prokaryotic and 
eukaryotic microalgae produce a range of compounds with biological activities such as 
antibiotics, algaecides and toxins 
6
. The focus of this study was those algae that produce 
toxins. Several species of cyanobacteria produce potent toxins 
2, 3, 6
 and about 30 species of 




Algal blooms incidents have recently increased especially with increased pollution of water 
bodies 
6
 and they are found in many eutrophic to hypertrophic water bodies throughout the 
world 
3
. The presence of blue green algae (also called cyanobacteria) in water bodies 
compromises the water quality. Their presence results in unpleasant colour, taste and odour 
of water and they are also capable of producing a wide range of potent toxins usually referred 
to as cyanotoxins 
3, 7
.   
 
There are about 40 genera of algae (cyanobacteria) that produce toxins but the main ones are 
Anabaena, Aphanizomenon, Cylindrospermopsis, Lyngbya, Microcystis, Nostoc and 
3 
 
Oscillatoria (Planktothrix). These organisms thrive in the presence of sunlight and warm 
temperature especially in polluted waters that are rich in nutrients and have a slow flow rate 
or are stagnant 
3
. They are also able to adapt to varying light conditions which results in their 
better survival compared to other algae 
2
.   
 
Cyanotoxins can be grouped into: cyclic peptides (hepatotoxic microcystins and nodularins), 
alkaloids (fresh water hepatotoxic cylindrospermopsin and neurotoxins such as anatoxin-a, 
anatoxin-a(s) and saxitoxins, the marine toxin aplysiatoxin, debromoaplysiatoxin and 
lyngbyatoxin-a), and lipopolysaccharides (LPS).  All are biotoxins 
3, 6
 and are known to cause 





Microcystins are cyclic heptapeptides with molecular masses (RMM) in the range 500-4000 
Da with the commonest in the range 800 -1100 
6
.  They are seven peptide-linked amino acids 
with two terminal amino acids of the linear peptide condensed to form a cyclic compound. 
Five of the amino acids are non-protein and mostly constant in microcystins. The other two, 




The general structure is: cyclo-(D-alanine - X - D-erythro--methyl aspartic acid - Z -  2S, 
3S, 8S, 9S-3-amino-9-methoxy-2, 6, 8-trimethyl-10-phenyldeca-4,6-dienoic acid-D-
glutamate - N-methyldehydroalanine), short form: [cyclo-(D-alanine-X-D-MeAsp-Z-Adda-
D-glutamate-Mdha], in which X and Z represent the variable (protein) amino acids which can 
be leucine (L) and arginine (R) in microcystin LR, arginine (R) and arginine (R) in 
microcystin RR, Leucine (L) and tryosine (Y) in microcystin LY etc . Microcystins have 
4 
 





Figure 1. 1: General structure of a microcystin 
 
Nodularins lack the two amino acids that distinguish microcystins and are therefore 
monocyclic pentapeptides. The general structure is: cyclo-(D-MeAsp-L-Arginine-Adda-D-
glutamate-2-(methylamino)-2-dehydrobutyric acid [Mdhd]) and they can be isolated from 
Nodularia spumigena. Nodularin has a molecular mass of 824 Da 
3, 6
.   The Adda amino acid 
is a typical structure in all cyclic peptide toxins. 
 




Microcystins are relatively polar molecules (due to  carboxyl, amino and amido groups) and 
the Adda residue gives them a partially hydrophobic character 
3, 8
. Therefore, they remain in 
the aqueous phase rather than being adsorbed on sediments or on suspended particulate 
matter 
8
. Nodularins have similar chemical properties, so they can be determined with the 
same method as for microcystins.  Determination of microcystins and nodularin in the same 
run by high performance liquid chromatography (HPLC) has been reported 
9
   and capillary 
electrophoresis (CE) can also be used for their confirmatory/complementary determination.  
 
Cylindrospermopsin is a tricyclic alkaloid cyanotoxin with a molecular mass of 415 Da that 
can be obtained from Cylindrospermopsis raciborskii. It is a cyclic guanidine alkaloid which 
is hepatotoxic and has been reported to cause severe liver damage but its symptoms are 
distinguishable from those of microcystins and nodularin 
6
. Exposure to cylindrospermopsin 
is associated with severe hepatoenteritis and renal damage. It affects several organs including 
the liver, kidneys, lungs, heart, stomach, adrenal glands and the lymphatic system, with the 
liver exhibiting centrilobular necrosis 
10
. Other variants of cylindrospermopsin are 
demethoxy-cylindrospermopsin and deoxy-cylindrospermopsin. 
 
Figure 1. 3: Cylindrospermopsin 
 
Cylindrospermopsin is hydrophilic, so it is often extracted and concentrated from water 
samples using graphitised carbon based sorbents 
3
. The toxin concentration in water is 





HPLC and CE methods for determination of cylindrospermopsin at the absorbance of 262 nm 
have been reported 
11
 but there are very few reports about simultaneous determination of 
microcystins together with cylindrospermopsin yet the two types of toxins may coexist in the 
same water body.   
 
Several methods have been developed for the determination of cyanotoxins in water, for 
example, the international organisation for standardisation method for determination of 
microcystins in water (ISO 20179:2005) is high performance chromatography (HPLC) with 
ultra violet (UV) detection at 238 nm after (solid phase extraction) SPE.  Generally methods 
for analysis of cyanobacterial toxins are divided into screening methods and those which can 
be used for purposes of identification and quantification as summarised in table 1.1. 
 
Among the physical methods for identification and quantitation, HPLC is the most commonly 
used. Total analysis times for conventional HPLC can take 45-60 minutes and the detection 
limits are 300-1000 µg/L without pre-concentration 
12, 13
 . A faster separation using a 
monolithic stationary phase was reported but the limit of detection was high (300 ng/mL) 
13
, 
even then, resolution between some analogues was poor. These detection limits are 
comparable to what can be achieved using capillary electrophoresis (CE) yet CE uses minute 
amounts of background electrolyte (e.g. 2 mL of BGE for a day) compared to HPLC (2-4 mL 
per minute of the run) 
13












Mouse bioassay is a widely used method, but it lacks sensitivity and is not 
suitable for quantitation 
14, 15
 because a large number of mice would be 
involved and usually a license is required to use them. It is qualitative, 
determines the amount of sample needed to kill a mouse; therefore it is a 
screen for the ability of a sample to be toxic. However, it shows poor 






Very sensitive. However, it lacks specificity as it will test positive in 
presence of other phosphatase inhibitors, moreover, it requires a purified 
enzyme and 
32
P isotope has a short half life. It is expensive due to the 
radioactive ATP and cost of enzymes. they have poor specific identification 
ability 
15
, usually used as a first screen 
4, 14
 
ELISA (screen) Very sensitive but it may experience variable cross-reactivity, have poor 
specific identification ability 
15
 and therefore may underestimate 
concentration. So it is usually used as a first screen 
4, 14
 
HPLC The most established and commonly used methods are based on HPLC 
7, 15, 
16
. However it can involve relatively lengthy analysis time and high solvent 
and chemical reagent consumption. More sensitive than mouse bioassay, and 
can distinguish the microcystins if standards are available. Using photodiode 
array (PDA) detection, characteristic UV spectra can be obtained to assist in 
identification of microcystins however, analysis time can be long and other 
analytes may absorb at the same wave length as microcystins. May not 
differentiate between the microcystin analogues.  
LC-MS Confirms analytes based on their mass spectra, sensitive and specific, 
equipment is expensive. 
CE Short analysis time, high separation efficiency, small sample volume, low 
solvent cost and little hazardous waste, however, It has low UV sensitivity 
due to small sample volumes used, analytes may need to be derivatised to 
improve sensitivity and detect with a fluorescence detector. Method requires 
further development to improve sensitivity. 
CE-MS Specific, equipment is expensive and interfaces still require development. 
 
The use of CE to separate related analogues of microcystins was reported and it was 
demonstrated to result in better resolution compared to HPLC methods 
12
. A simple CZE 
BGE can be used to separate microcystins in less than 20 minutes with detection limits 
(LOD)  of 0.8 – 4.8 µg/mL 17.  This LOD is comparable to LODs obtained using HPLC with 
UV detection yet the total run time in CE is shorter. Based on better resolution and shorter 
analysis time, there are significant advantages in using CE for determination of microcystins 




Vasas et al 
11, 18
 and Onyewuenyi et al 
19
 demonstrated that CE can be used to separate 
microcystins and the successful mode of CE employed was micellar electrokinetic 
chromatography (MEKC) using SDS. The use of capillary electrokinetic chromatography 
(CEC) has also been reported 
20
. In most of these methods, about three microcystins were 
determined from algal masses and their determination in drinking water was not emphasized. 
Furthermore, there is a challenge of the  high detection limits in CE methods compared to the 
requirement for the drinking water guideline of 1 µg/ L as proposed in WHO drinking water 
guidelines
1
, but this can be solved using pre-concentration techniques. 
 
In the first phase of our study, CZE and MEKC methods for the determination of four related 
cyanobacterial hepatotoxins (microcystin RR, microcystin YR microcystin LR and nodularin) 
in drinking water were investigated because they occur most frequently compared to other 
microcystins. Satisfactory separation was obtained and the methods were validated for the 
determination of hepatotoxins in drinking water. The methods demonstrated the potential to 
be applied to a wider range of microcystins because the resolutions between adjacent peaks 
were good.  Microemulsion electrokinetic capillary electrophoresis (MEEC) was used for 
simultaneous separation of a bigger group of microcystins together with nodularin and 
cylindrospermopsin using sodium tetraborate as the back ground electrolyte (BGE) in the 
second phase. Good separation of the analytes was obtained. In this study, we developed 
capillary electrophoresis methods for a portable CE instrument to determine microcystins in 
water in order to harness the inherent advantages of CE (speed, resolution, and smaller 





The amount of cyanotoxins in water bodies is of concern because that is the most likely mode 
through which animals and humans are exposed to the toxins.  Exposure to cyanotoxins in 
high amounts has been reported to be hazardous, but the effect of exposure of humans to low 
amounts of these toxins had not been reported. Therefore, the toxic effects of microcystins 









The effects of exposure of a human cell line to non cytotoxic concentrations of the most 
frequently occurring microcystins (LR, RR and YR) were investigated in this study using 
“metabolomics” and “metabonomics” approaches. HepG2 cell line was used and the cells 
were incubated in media containing different concentrations of the individual microcystins as 
well as media containing a mixture of the three microcystins because in a real situation, there 
is a likelihood of occurrence of more than one microcystin in a water body and thus a 
possibility of exposure to more than one microcystin at the same time. Aliquots of media 
were collected at different time intervals, extracted and analysed to obtain a finger/footprint 
of the metabolic profile after exposure.   
 
The WHO drinking water guideline is 1µg microcystin LR per litre or its equivalent 
1
, 
however, most of the literatures report investigations of microcystin toxicity at higher doses 
and studies of effects at a low dosage exposure over a long term (chronic toxicity) mainly 
focused on gene expression and DNA damage, for example it was reported that microcystin 
LR  in low amounts ( 2- 20 g/L) altered the profile of proteins in zebra fish. The proteins 
which were affected were involved in cytoskeleton assembly, macromolecule metabolism, 
oxidative stress and signal transduction 
21
. The metabolomics approach just like other global 
techniques offers a holistic analysis. By profiling all the metabolites, it is possible to obtain 
10 
 
an unbiased marker compared to conventional approaches of investigation of toxicity such as 
analysis of enzyme activity 
21
. Furthermore, there are reports describing the effects of 
microcystins on DNA strands, induction of oxidative damage and apoptosis, effect on 
glutathione levels and production of reactive oxygen species (ROS). The metabolic approach 
monitors the actual effect on the metabolic balance in effect giving a clear picture of what is 
going on in the organism and such an approach has not been reported before. 
 
 
1.2 Statement of the Problem 
 
The importance of water quality cannot be overstated. Fresh water shortages and water 
pollution are among the current environmental issues of concern 
22
. Lakes and reservoirs are 
vulnerable to overloading of nutrients and therefore eutrophication has become a serious 
problem 
23
.Water eutrophication is of concern because it affects the normal balance of aquatic 
life. It increases turbidity as well as plant and animal biomass. As a result there is increased 
competition for nutrients and survival. Algal blooms are known to occur in high 
eutrophication conditions. These can include blue green algae (cyanobacteria) which produce 
a range of compounds that are of concern. For this research, the focus was on cyanobacterial 
toxins of the microcystin group. This is because microcystins are most commonly occurring 
cyanobacterial toxins worldwide and they are known to be responsible for poisoning of 
domestic and wild animals and in some instances humans
2, 4, 5
. They are well known 
hepatotoxins; they inhibit the protein phosphatases inside hepatocytes thus causing liver 
damage. With increasing waste disposal into waters, eutrophication has increased and so have 
the occurrence of microcystins and the likelihood of poisoning from drinking contaminated 
11 
 
waters. There is therefore a need to develop an adequate analytical method for determination 
and quantification of cyanotoxins in water bodies to monitor contamination. 
 
The ISO method for determination of microcystins is based on HPLC-UV but solid phase 
extraction has to be used to detect amounts in accordance with WHO water requirements; 
LC-MS methods have also been described with lower detection limits however they are 
characterised by long analysis time moreover most of these instruments are bench top sizes 
and are not easily applied in field. There is a need to develop an analytical method that can be 
applied on site. Capillary electrophoresis techniques are suitable in this application because 
they are known for shorter run times, they use small amounts of sample and solvent moreover 
a portable instrument was available. The methods developed for this portable system can be 
applied on site for quicker analysis and more representative information.  
 
Microcystins are hepatotoxic and are said to induce necrosis at high doses (acute toxicity). 
They inhibit serine/threonine phosphatases 1 and 2A, cause cytoskeletal damage, liver 
necrosis and haemorrhage in the liver. Epidemiological studies have suggested that 
microcystins are one of the risk factors for the high incidence of primary liver cancer in 
certain areas of China 
24
 and microcystin LR has been reported to induce oxidative DNA 
damage in human hepatoma cell line HepG2. Microcystins have been reported to be 
responsible for fatalities of animals and humans 
25, 26
. Microcystin LR in low concentration 
(nM) caused a collapse of actin filaments in human primary hepatocytes 
27
 and more recently 
microcystin were detected in sera of a chronically exposed human population in China 
28
 
which demonstrates a health risk of chronic exposure. Microcystin LR and nodularin were 
reported to induce time dependent intracellular glutathione alteration 
29, 30
 and production of 
reactive oxygen species (ROS) and to induce lipid peroxidation in rats 
30, 31
 which are 
12 
 
characteristic of oxidative stress. Oxidative lipid metabolism following acute hepatotoxicity 
32, 33
, induction of apoptosis and nephrotoxicity 
34
 have also been reported. Furthermore, 
Microcystin LR has been implicated in causing DNA strand breaks 
24, 29, 35, 36
.  It is therefore 
evident that exposure to microcystins is hazardous; the issue at hand is to determine whether 
chronic exposure to low concentrations of microcystins may eventually lead to liver injury 
which would be a health risk and what mechanisms are involved. This is because in humans 
the likelihood of chronic exposure is higher than that of acute exposure in everyday life. 
 
 
1.3 Scope of Research 
 
 
1.3.1 Research Aims/Objectives 
 
The general aim of this research was to develop analytical methods for determination of 
cyanobacterial toxins in water and to investigate the potential effect of exposure to 
microcystins using “metabolomic” and “metabonomic” approaches. 
 
The specific objectives of this study were to: 
 Develop capillary electrophoresis (CE) methods for determination of microcystins in 
drinking water  
 Investigate the effect of exposure of a human cell line to non cytotoxic amounts of 
microcystins using proton nuclear magnetic resonance (
1





In this study, CE technique was selected because of its advantages of good resolution and low 
solvent consumption. Methods for determination of cyanobacterial toxins in water were 
developed because contaminated water is the most common exposure route and the methods 
were developed for a portable capillary electrophoresis instrument to allow for determination 
of cyanobacterial toxins on site.  
 
The current interest in cyanobacteria toxins research is mainly due to increased awareness of 
the harmful effects from exposure. Skin irritations, death of dogs and cattle have been linked 
to microcystin exposure  
37
 and human fatalities were reported after exposure to cyanotoxins 
during dialysis in Brazil 
26, 38
. Moreover exposure to low levels of hepatotoxins has been 
linked to development of tumours and cancers by an epidemiological study in China 
39
. This 
increasing evidence shows that low levels of exposure may have chronic deleterious effects 
in humans 
14
. Therefore it is important to determine microcystins in drinking and other waters 
even at low concentrations because in addition to immediate effects attributed to exposure at 





Exposure to cyanobacterial toxins in human is not obvious and in most cases human are 
prone to chronic exposure to low concentrations of microcystin (e.g. in work related exposure  
such as in fishermen exposed to contaminated water, swimming in contaminated water). It is 
important to investigate whether continued exposure is hazardous. Different holistic 
approaches for investigation of biosystems can be used but "metabolomics” and 
“metabonomics” offer a direct representation of what is going on in the system before 




The “metabolomics” approach was used to investigate the effects of microcystin toxicity 
because it generates a unique “finger/footprint” of the cellular processes going on. 
Compounds measured have a direct effect on the phenotype, the changes in metabolites can 
be monitored in a time and concentration dependent manner and the effect on the whole 
organism is determined. The results can be related to classical toxicological end points such 
as LC50 and compared to other techniques like “proteomics” and “genomics”, the components 
monitored can be directly related to exposure to xenobiotics for example if the xenobiotic 
binds or inhibits certain enzymes in effect controlling metabolism moreover metabolite 
monitoring is usually done for a whole organism/system. 
 
Capillary electrophoresis the method of choice for this analysis is described in the following 
section. 
 
1.4. Capillary Electrophoresis - Basic Principles  
 
Electrophoresis can be defined as differential migration of electrically charged particles in a 
conductive medium under the influence of an electrical field 
40-42
. The medium can be a gel 
(as in gel electrophoresis) or can be a liquid, in most cases a buffer solution. In capillary 
electrophoresis, the medium is contained in a small capillary 
40
. Therefore capillary 
electrophoresis can be described as a separation of sample ions in a narrow bore (25 - 100 µm 
diameter) 
41
 or separation of a mixture in a capillary tube due to differing ionic mobilities 
induced by application of a high voltage along the capillary 
43
. A schematic diagram of a 





Figure 1. 4: Schematic diagram of capillary electrophoresis system 
 
High performance capillary electrophoresis (HPCE) does not require the use of gels because 
the capillary walls provide mechanical support for the carrier electrolyte.  Small diameter 
capillaries are used to obtain large ratios of surface area to volume, which enables sufficient 
heat dissipation and thus allows usage of high voltages necessary for quick and efficient 
separations 
40
.The emergence of HPCE solved some of the difficulties associated with gels 
such as the difficulty for automation. Furthermore, sample introduction can be performed in a 
repetitive manner, detection is on column, and the instrument output is easier to interpret 
since it resembles a chromatogram 
 40
. Capillary electrophoresis is a commonly a serial 
technique compared to slab-gels which have a high throughput because multiple samples can 
be separated at once but capillary arrays have been developed  to achieve high throughput 
42
 






1.4.1 Sample Introduction 
 
In CE, a sample can be introduced into the capillary by electrokinetic injection or 
hydrodynamic injection. Electrokinetic sample injection is achieved by applying a high 
voltage at the inlet end of the capillary for a short time. Figure 1.5 shows sample introduction 
by electrokinetic injection. Analyte ions migrate into the capillary by a combination of 
electrophoretic migration of the ions and electroosmotic flow of the sample solution. 
 
 
Figure 1. 5: Electrokinetic injection 
 
The length of the sample zone introduced into the capillary (  in cm) is described by:  
       (i)                                   
Where:  (in cm s
-1
) is the electroosmotic velocity of the bulk solution 
 (in cm s
-1





For a short injection time,   
 
        (ii) 
   
 and  
 
Where, 
  E (in V cm-1) is the electric field strength = V/L,   (in cm2/Vs) is the electroosmotic 
mobility, (cm
2
/Vs) is the electrophoretic mobility of ion. 
 
The amount of sample injected in nL/s (mi) will be proportional to the injection length i.e. 
       (iii) 
where:   
 is the cross sectional area of the capillary ,  is the concentration of the ionic species and 
 is the injection time in seconds.  
 
Hydrodynamic injection takes advantage of pressure differences between the inlet and outlet 
of the capillary which can be achieved by gravity, vacuum at the outlet or increasing the 
pressure at the inlet 
44
. Hydrodynamic injection by gravity is sometimes referred to as 
siphoning. The sample vial is raised to a specific height (dH) for a short time interval and the 
sample is injected into the capillary due to the hydrostatic pressure difference created at the 




Figure 1. 6: Injection by gravity (siphoning) 
 
 
Hydrodynamic injection by pressure/ vacuum is achieved by applying a low pressure (often 










The length of the sample zone injected can be obtained from 
44
:  
        (iv) 
 Where:   is the total injection time, is hydrodynamic flow velocity and  
When the flow velocity is constant the length of the sample injected can be obtained from,  
           (v) 
The flow velocity can be described by Poisseuille equation 
44
: 
          (vi) 
Where, 
  is the pressure difference between the inlet and outlet of the capillary,  is the diameter 
of the capillary,  is the viscosity of the liquid and  is the capillary length. 
 
For injection by gravity, 
         (vii) 




 and  is the height to which the sample vial is raised. 
 
In general the pressure required for a normalized injection length (effective injection 
volume),  




 is the normalised injection length,    is the injection time and  is the capillary 
internal diameter. 
 
By varying the pressure and injection time the sample zone length injected can be controlled 
44
. Hydrodynamic injection can be regarded as a universal injection mode in CE since is not 
biased by the sample or matrix but there is a need to control the pressure to optimise 
injection. This was the method employed to introduce analytes into the capillary in this 
research. 
 
1.4.2 Sample Separation 
 
Sample ion migration in capillary electrophoresis occurs as a result of the interplay between 
the electrophoretic mobility of the sample ions and the electroosmotic force. This determines 
the migration speed and the order of migration of the sample ions. 
 
1.4.2.1 Electrophoretic Mobility 
 
Upon application of a high voltage, ionic species in the sample migrate towards the electrode 
of opposite charge. Their speed or electrophoretic mobility and their direction are determined 
by their charge and mass 
42, 44
. 
Electrophoretic velocity of an ion i,      (ix) 





 is the electrophoretic mobility ,  is the charge on the particle, is the viscosity of 
the buffer and  is the radius of the particle. 
 
The mobility of an ion is directly proportional to its charge and inversely proportional to the 
radius of the ion and the viscosity of the buffer solution. Therefore, highly charged ions with 
a smaller size will migrate towards the oppositely charged electrode faster in a solution of 
low viscosity. 
 
1.4.2.2 Electroosmotic Mobility 
 
Fused silica capillaries are the most commonly used capillaries in CE. When the pH is above 
3, the inner surface is ionised 
44
. The ionised silanol (SiO
-
) groups attract cationic species 
from the buffer forming a double layer. The ionic layer that is formed has a positive charge 
density which decreases as the distance from the wall increases. The double ion layer closest 
to the surface of the capillary (inner Helmholtz layer/stern layer) is static but the layer 
towards the inner part of the capillary (outer Helmholtz plane) is more diffuse. 
Under an applied field, cations in the diffuse outer layer migrate towards the cathode at the 
same time carrying water of hydration molecules with them. This in turn causes the entire 
bulk of the solution to follow course due to hydrogen bonding between water of hydration 





Figure 1. 8: Illustration of EOF inside a fused silica capillary 
 
 
This force is called electroosmotic flow (EOF) and it leads to an overall movement of the 
bulk solution towards the cathode if the silica capillary wall surface is bare. In this way all 
species are carried towards the cathode in the order: cations, neutral ions and anions. Figure 
1.9 illustrates the order of migration for a mixture of cations, anions and neutral species. EOF  
can be manipulated by changing the pH of the solution or coating the capillary wall  resulting 








The migration of the ion is due to electrophoretic mobility and electroosmotic mobility. 
      (xi) 
Where:   is the electrophoretic mobility   is the electroosmotic mobility 
 Apparent mobility     is the electric field strength 
 
EOF has a flat profile rather than a parabolic profile (figure 1.10) which occurs in pressure 
driven flows. This profile is a significant feature of EOF driven separations because it 
reduces solute band broadening caused by differences in the bulk  velocity  and in effect it 

















1.4.3 Detection in Capillary Electrophoresis 
 
Conventional high performance capillary electrophoresis (HPCE) was developed based on 
high performance liquid chromatography (HPLC). The most common standard detection 
methods that are commercially available are based on measurement of optical characteristics 
such as absorbance and fluorescence 
42, 45, 46
. Detection by UV absorbance is versatile and 
well suited for UV-absorbing analytes. For non UV-absorbing analytes indirect measurement 
can be used although sensitivity is usually low. Indirect measurement is done by spiking 
excess amount of chromophoric species. Sensitivity in both cases is also limited by the short 





Detection by laser induced fluorescence (LIF) is one of the most sensitive detection methods 
for many biochemical species, but it is limited by cost, the limited choice of excitation 
wavelength, time and labour intensive procedures involved in labelling non-fluorescent 




Electrochemical techniques such as amperometry, potentiometry and conductivity are not as 
widely used because of poor sensitivity. Amperometry and potentiometry are applied to 
detect specific analytes (those that can undergo redox reactions), but conductivity is a 
universal principle which in theory can be applied to all charged analytes and to uncharged 
analytes separated by micellar electro kinetic chromatography (MEKC)






1.4.4 Modes of Capillary Electrophoresis 
 
Capillary electrophoresis (CE) has various modes which use narrow-bore capillaries e.g. 
fused-silica to separate different compounds with differing mechanisms of separation. 
Separation of analytes is based on differences in charge, size and hydrophobicity. The 
different modes include: 
 
Capillary zone electrophoresis (CZE) is one example of free-solution CE (FSCE). This is the 
simplest form of CE, in which a narrow bore capillary is filled with a homogeneous 
background electrolyte (BGE) and a constant field is applied across the ends of the capillary. 
The separation mechanism is based on differences in the charge-to-size ratio of the analytes 
42, 44
. The important parameters to manipulate so as to obtain the best separation are: applied 
voltage, the choice of buffer and its ionic strength as well its pH. Organic modifiers can also 




Capillary gel electrophoresis (CGE) employs polymers in solution which are used to create a 
molecular sieve to allow analytes having similar charge-to-mass ratios to be resolved 
42, 44
. 
Separation of analytes is based on differences in size. 
 
Capillary isotachophoresis (ITP) is a free solution focusing technique based on the migration 
of the sample components between leading and terminating electrolytes. Solutes with 
mobilities intermediate to those of the leading and terminating electrolytes stack into sharp, 
focused zones 
42, 44
 and are usually separated by CZE. 
 
Micellar electrokinetic capillary chromatography (MECC OR MEKC) is also a free solution 
technique where surfactants are added to the buffer solution at concentrations over their 
26 
 
critical micellar concentration (cmc) so that they can form micelles. Separation is based on 
the differential partition between the micelle and the buffer.  MEKC is applicable to both 
charged and neutral analytes and is very useful in separation of hydrophobic compounds 
42, 44
. 
Addition of organic modifiers to the mobile phase decreases the extent of partition of non 





Microemulsion electrokinetic chromatography (MEEKC or MEEC) is a CE technique in 
which solutes partition into moving oil droplets in a buffer. The micro-emulsion droplets are 
usually formed by sonicating immiscible heptane or octane with water to make an “oil in 
water” emulsion even though a “water in oil” emulsion can also be considered. A surfactant 
such as sodium dodecyl sulphate (SDS) is added at relatively high concentrations to stabilize 
the emulsion. This allows the separation of both aqueous and water-insoluble compounds. 
The surfactant helps to reduce the surface tension between the oil and aqueous phases and the 
surface tension is further reduced by incorporating a co-surfactant in most cases a short chain 
alcohol such as butanol which stabilises the microemulsion system 
47
.  Chromatographic 
separation occurs by partition of solutes between the oil phase and the aqueous phase with 
hydrophobic compounds staying in the oil phase and as a result they are separated from the 
hydrophilic compounds which elute faster. Hydrophobic analytes in the oil phase are covered 
in negative charge when an anionic surfactant is used  and since it will migrate against the 
EOF, they stay longer in the capillary 
48
. Separation in MEEC is based on 
hydrophobicity/hydrophilicity as well as electrophoretic migration; this technique can 




Non-aqueous capillary electrophoresis (NACE) allows additional selectivity options in 
methods development and is also valuable for the separation of water-insoluble compounds. 
The medium is composed of organic solvents and solvents of a relatively high permittivity, 
low viscosity, and low vapor pressure are preferred. Parameters such as resolution, analysis 
time and selectivity can be easily adjusted by the composition of the medium or background 
electrolyte. Separation of compounds  by NACE can be achieved when the analytes are 





Capillary electro-chromatography (CEC) can be described as a hybrid technique which 
combines the high separation efficiency of CZE with HPLC but uses an electric field rather 
than hydraulic pressure to propel the mobile phase through a packed bed. The capillary is 
packed with a stationary phase or the stationary phase may be synthesised in situ to make a 
monolithic capillary. The different stationary phases available offer an advantage of 
selectivity 
43
 and CEC is also used during on-column analyte concentration to pre-concentrate 
a given sample prior to separation by CZE 
42, 44
. CEC is greatly impacting on CE techniques 
but is still limited by development in instrumentation and stationary phases. 
 
Capillary isoelectric focusing (CIEF) is a free solution CE technique in which solutes are 
separated by focusing them at their isoelectric points. The charge-to-mass ratio for each 
solute determines its migration, the solute will not migrate when it is neutral, at its isoelectric 
point, and this is the principle applied in isoelectric focusing. A pH gradient is generated 
between the cathode and anode using carrier ampholytes. Each solute will migrate to a point 
where its net charge is zero (isoelectric point or pI), at this point migration stops and the 
sample is focused into a tight zone. The zone is then mobilized past the detector by either 
28 
 





In the first phase of this study, the simplest modes of CE, CZE and MEKC were developed 
for determination of microcystin LR, microcystin RR, microcystin YR, and nodularin. In the 
next phase, an MEEC method was developed for determination of a wider range of 
cyanobacterial hepatotoxins microcystin LA, microcystin LF, microcystin LR,  microcystin 
LW,  microcystin LY, microcystin RR, microcystin YR, nodularin and a hepatotoxic alkaloid 
cylindrospermopsin  in drinking water. Satisfactory separation was obtained for all the three 
modes of CE and the methods were validated for the determination of hepatotoxins in water.  
 
 
1.4.5 Pre-concentration Techniques in Capillary Electrophoresis 
 
As described earlier, capillary electrophoresis (CE) is a powerful separation technique. It has 
continued to develop with application in various fields such as environmental analysis, 
pharmaceutical and clinical analysis. This is largely due to its inherent advantages of high 
speed, high efficiency of separation and it is environmentally friendly due to the use of small 
amounts of sample and reagent compared to other separation methods like HPLC 
50
. The 
limiting factor however is poor sensitivity when on-lcolumn UV detection is employed. This 
limitation is due to small loaded sample volume and the narrow optical path length since 




Different techniques have been used to improve sensitivity in CE. These are generally 
divided into instrument modifications mainly to increase the optical path length such as use 
29 
 
of a bubble cell, Z-shaped or multiple-reflection capillaries; and sample pre-concentration 
techniques to increase the amount of sample injected.   
 
Sample pre-concentration can be achieved by off line methods such as solid phase extraction. 
In recent trends online concentration techniques have been used 
51
 because they are not as 
time consuming as off line methods. 
 
 
1.4.6 Online Sample pre-concentration methods 
 
These techniques  rely on manipulation of the electrophoretic mobility of the sample ions for 
example in  stacking (large volume sample stacking,  field amplified stacking,  pH-mediated 
stacking, dynamic pH junction stacking, use of solvent plugs); or partitioning into a 
stationary phase or a pseudo stationary phase which affects pre-concentration of the sample 




.  These techniques can be performed 





Stacking is based on the differences in the electrolyte properties between the sample and the 
BGE. Sample stacking occurs when sample ions move across a boundary which separates the 
region of the sample ions from the rest of the capillary containing the BGE.  Examples 
include sample stacking, pH mediated stacking.  Alternatively stacking can be achieved by 
taking advantage of chromatographic effects such as in using monoliths or using 
30 
 





Large volume sample stacking (LVSS) pre-concentration technique involves injection of a 
sample dissolved in a low conductivity background electrolyte (BGE) or in water for a long 
injection time. It can also be performed with  polarity switching to reverse the direction of the 
EOF
53
. This method is sometimes referred to as reversed electrode polarity stacking mode 
and can be applied in microemulsion electrochromatography 
54
. In positive polarity, anionic 
components will move towards the detector and stack at the boundary between the sample 
zone and the BGE, while the cations and neutral species exit the capillary at the inlet end. 
When the current reaches its original value, the polarity is quickly switched to the original 
one leading to a reversal of EOF and separation of the sample ions occurs by CZE.  Injection 
time must be optimized and current monitored. This method is useful for low mobility ions 




In field amplified sample stacking (FASS) the sample is dissolved in a low-conductivity 
BGE. A sample solution is injected into the capillary for an injection time usually longer than 
the normal (5-10 s) injection time. When a high voltage is applied, a greater electric field 
develops across the sample zone causing the ions to migrate more rapidly. At the boundaries 
between the sample zone and the BGE, the electric field strength suddenly decreases and 
migration becomes slower, causing the sample ions to be focused near the boundaries. The 
analytes will finally be carried towards the detector by the EOF whose mobility is greater 
than that of the sample ions 
50, 51
. This method works well with electrokinetic injection and 
besides injection voltage, sample injection volume has to be optimized to obtain adequate 





Another pre-concentration technique that can be used for online sample pre-concentration is 
pH mediated stacking where the sample is prepared in a high-ionic strength medium and is 
electrokinetically injected into the capillary. Then, a plug of strong acid is injected and a 
positive separation voltage is applied. The sample solution is titrated by the acid to create a 
neutral high-resistance zone. Therefore a greater field will develop across the neutral zone 
causing the ions to migrate faster. As a result, the analytes are stacked at the boundary 
between the titrated zone and the BGE followed by CZE separation 
51
. The use of pH can also 
be applied by injecting a sample in matrix whose pH is different from that of the BGE. This 
is referred to as dynamic pH-junction stacking and it is applicable to weakly ionic analytes 
that have mobilities which change as a function of buffer pH. This method is mainly applied 












Sweeping in electrokinetic chromatography can also be used for sample pre-concentration. 
The sweeping technique was originally developed for the online pre-concentration of neutral 
analytes in electrokinetic chromatography (EKC). Sweeping can be used whether the sample 
matrix has a similar or different conductivity from the BGE however it should be devoid of 
the pseudo stationary phase (PS) 
50
. The principle involves accumulation of sample/analytes 
by the pseudo stationary phase which fills and penetrates the sample zone on application of 
voltage. Separation is by electrophoresis which causes the charged PS to move and penetrate 
the sample zone. Sweeping is applicable to analytes that have a strong affinity to the PS 
irrespective of the charge. 
 
 




1.4.6.3 Combination of   Pre-concentration Techniques 
 
Dynamic pH Junction–Sweeping: This technique combines dynamic pH junction and 
sweeping. The sample is prepared in a matrix of a different pH from that of the BGE without 
the PS. This combination of focusing techniques focuses both neutral and weakly ionic 
species, and in so doing improves the performance of stacking compared to conventional 
sweeping or the dynamic pH junction technique used alone 
50
. The focusing effects of buffer 
pH, borate complexation and SDS partitioning have been reported to result in enhanced 
analyte band narrowing improving the overall sensitivity. 
 
Selective-exhaustive injection–sweeping (SEI-sweep): In SEI- sweep, sample stacking in 
combination with electrokinetic injection is performed over a much longer period of time 
than usual (e.g. 400 s). The electrokinetic injection is selective for either cationic or anionic 
analytes. Prolonged electrokinetic injection can deplete the sample solution of analytes in the 
inlet vial therefore a fresh solution of the sample is required for every new injection to 
achieve reproducibility. Samples are prepared in low conductivity matrix and the method 




For cationic analytes the method used is cation selective exhaustive injection–sweeping 
(CSEI-sweep), where the capillary is first filled with nonmicellar BGE at low pH to suppress 
the EOF. This is followed by a high conductivity buffer (HCB) and a water plug. The water 
plug during the CSEI step helps to maintain a high electric field at the tip of the capillary, 
which allows the cationic analytes to enter the capillary at high velocity improving the 
stacking effect. The water plug and the HCB create a long sample zone to achieve a higher 
concentration than would normally be achieved in the original BGE solution. In the absence 
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of a water plug, analytes stack at the injection point and this affects field enhancement. The 
high-conductivity buffer (HCB) improves the total stacking effect of the analytes. It allows 
the injection of sample ions over a long period thus, increases the amount of sample injected 




Anionic analytes are focused using anion-selective exhaustive injection–sweeping (ASEI-
sweep). In this method, cationic micelles are used as carriers for the anions. EOF is also 
suppressed and polarities are reversed compared to CSEI. The anionic sample solution is 





Some modifications of the SEI-sweep have been employed including using a microemulsion 
solution instead of a micelle, or the use of an acid plug ASEI-sweep or a basic plug for CSEI-
sweep. These have been reported to improve the total stacking time and in effect detection 
sensitivity. Use of a salt in high salt stacking electrochromatography has also been reported 
55
. In this research, large volume injections together with a solvent plug were used in attempts 
to pre-concentrate the sample online and improve the limits of detection for the analytes 










1.5. Metabolomics and Metabonomics - Introduction 
 
Metabolomic techniques have been widely applied in several studies for example in 





, in toxicity assessment of drugs  and other studies to 
investigate differences in individuals’ metabolisms60. In this project, the “metabolomics” and 
“metabonomics” approach was used to investigate the toxicity of microcystins which are 
potent hepatotoxins with the aim of identifying markers for hepatotoxicity as a result of 
exposure to low concentrations of microcystins LR, YR and RR. 
 
“Metabonomics” is defined as "a quantitative measurement of the dynamic multi-parametric 
metabolic response of living systems to pathophysiological stimuli or genetic modification”. 
“Metabolomics” on the other hand refers to “a comprehensive analysis in which all the 
metabolites of a biological system are identified and quantified” 61, 62. Living organisms have 
a range of endogenous small molecules such as sugars, amino acids and organic acids in 
addition to macromolecules such as proteins and nucleic acids. Most of these are products 
and or intermediates of metabolic reactions although some may be externally acquired from 
their environment. A comprehensive analysis of the organism’s metabolome (total small 
molecule complement of the cell 
61





There is a growing interest in systems biology, a field which uses holistic approaches to 
describe biological interactions. Components of a system and their interactions are studied to 
understand their total effect on an organism or a biosystem. This interest led to the 
development of the “-omic” studies including “genomics”, “proteomics” and 
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“metabolomics”. According to Dettmer, Aronov and Hammock 64 integration of the 
responses of an organism to external stimuli at the genomic, transcriptomic and metabolomic 
levels can lead to a better understanding of the biochemical and biological processes in a 
complex system. Figure 1.13 is a schematic diagram of the relationship between genomics, 
proteomics and metabolomics.  
 
 
Figure 1. 13: Schematic of the relationship between genomics, proteomics and metabolomics 
 
Genomics describes the genotype (genetic makeup)and is largely responsible for the 
phenotype (observable trait) therefore it is responsible for what can happen, however other 
factors such as the environment can also affect the phenotype. Genetic information in DNA is 
transcribed by messenger RNA which carries this information into the ribosome where 
protein synthesis occurs. In proteomics, proteins are profiled and studied to understand their 
structure and function so as to understand how they affect the biosystem. It leads to an 
understanding of different cellular processes in the cell. Metabolic profiling focuses on a 
group of metabolites related to a specific metabolic pathway or on a class of compounds. 
Mainly low molecular weight compounds which are substrates, intermediates and or end 
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products of biochemical reactions are analyzed. These compounds have a direct effect on the 
phenotype of the cell or organism or biosystem and as such provide a clear picture of what 




Bioanalytical approaches for measurements of effects of xenobiotic exposure on biosystems 
have mainly been based on investigations at genetic level (genomics) or at the level of 
expression of cellular proteins (proteomics).Techniques  such as proteomics and 
transcriptomics are powerful and generate a wealth of information about the different 
responses of a system to external factors but they are expensive, labour intensive 
61
 and they 
do not put in consideration the dynamic metabolic status of the whole organism. 
 
 
“Metabolomics” and or “metabonomics” investigates the organism’s metabolome and 
therefore complements the information obtained by genomics and proteomics 
61
 and 
integration of information at the genomic, transcriptomic, proteomic, and metabonomic levels 
provides a comprehensive understanding  of a system’s biology 62, 64. The important 
characteristic of “metabolomics” is that it provides information about the quantities of 
substances interest in an organism as well as the conditions in which they are present for 
example diseased versus normal state, and in effect the dynamic behaviour of an organism’s 
metabolism can be understood 
63
. Furthermore, the metabolome is the most predictive of the 
phenotype 
64
, so its profile is key to understanding what is going on in the biosystem. 
 
The terms “metabonomics” and “metabolomics” are used to refer to measurement of low 
molecular weight metabolites (up to 1000 Da) 65 and their intermediates in a biological 
system in response to external stimuli 
65
. Generally the aim is to generate an endogenous 
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metabolite profile, a unique fingerprint of the cellular processes that occur in a biological 
system, i.e. a comprehensive report of all the small molecules in the biosystem 
61
. It provides 
many opportunities to investigate and understand changes caused by external stimuli 
65
. For 
the purpose of this report, the term “metabolite finger/footprinting” was adopted to describe 
“metabonomics” where patterns of metabolites are the main differentiation tool; and 
“metabolite profiling” to describe “metabolomics” where the metabolites are identified and 
quantified. 
 
The study of metabolites in an organism provides a comprehensive signature of the 
physiological state of the organism and gives an insight into its biochemical process. The 
metabolome when monitored as a function of time allows for understanding the dynamics of 
homeostasis as well as the effects of external substances on the system 
66
 because metabolites 
play a significant role as building blocks and energy transporters in biological systems. 
 
Metabolites and small molecules investigations started in the early 1970s. At the time, studies 
were mainly concerned with alterations in biological systems such as those caused by disease 
and inborn errors of metabolism. This was followed by studies on effects of external factors 
such as stress, drugs and infection with viruses on the organism’s metabolic profile in the 










1.5.1 Analytical Techniques in Metabolomics 
 
Metabolomics involves quantification of a large number of compounds. Comprehensive 
analysis is challenging due the complexity and dynamics of the metabolome, therefore 
complementary approaches of “metabolic profiling” (metabolite identification) and 
“metabolic finger/footprinting” (pattern recognition techniques) are often used in 
metabolome analysis. Due to the large number of compounds and the large dynamic range, 
high throughput techniques are used. An ideal analytical technique should be able to identify 
and quantify every component present, however, this is a challenge considering that 
metabolites have a range of chemical properties and span a wide concentration range (pg - µg 
per litre). Therefore it is important to strike a balance between minimizing sample preparation 
to avoid sample loss and removing larger and more abundant components so as to increase 




Techniques used include: proton nuclear magnetic resonance spectroscopy (
1
H NMR), direct 
injection mass spectrometry (DIMS), liquid chromatography - mass spectrometry (LC-MS), 
gas chromatography - mass spectrometry (GC-MS) and capillary electrophoresis often with a 
mass spectrometer (CE-MS). The data obtained is usually interpreted using multivariate 
statistics and chemometric techniques 
62, 63
. The analytical techniques mentioned above, their 
advantages and drawbacks are described in the following section. 
 
The conventional technique used for metabolite analysis is 
1
H NMR spectroscopy. 
1
H NMR 
is used to examine the proton spectrum of the sample and as such every component with a 
proton can be detected and thus has a wide applicability. The spectrum usually consists of 
many peaks with each peak representing a different chemical environment based on 
resonance of the 
1
H nuclei. This is the basis of chemical classification. Generally, more stable 
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structures are positioned to the left and more flexible structures to the right so components 
are in the order: aromatics, sugars, organic acids and aliphatic compounds from left to right 




H NMR requires minimal sample 
preparation, generates a wealth of information about the compound classes and chemistries 
simultaneously with high analytical precision in a short time. It provides information on 
molecular structure for pure compounds or those in mixtures, has a quantitation ability 
because peak area/intensity is directly proportional to concentration and is non destructive of 
the sample. However, it has the limitation of poor sensitivity for compounds in very low 
concentration (ng per mL) so it is useful for profiling components in the higher concentration 
(g per mL and above) range of the metabolome 62, 65, 66. 
 
Mass spectroscopy (MS) is widely applied in metabolomics. It has the ability to provide 
information about the specific molecular masses and mass to charge ratios of the compounds. 
In direct injection mass spectrometry (DIMS) there is no chromatographic separation. DIMS 
is a high throughput technique and takes a short overall analysis time (2 min) per sample. 
The short analysis time increases inter-sample reproducibility and improves the accuracy in 
subsequent cluster analysis. However, chemical isomers cannot be distinguished by this rapid 
screening technique and in the case of electrospray ionization there is concern about ion 




When MS is coupled with a separation technique such as liquid chromatography (LC), gas 
chromatography (GC) or capillary electrophoresis it becomes even more powerful because in 
addition to mass to charge values and molecular masses, compounds can be separated and 
isomers are identified. In LC, different columns are often used in order to separate a wide 
range of compounds (with different properties) and quantitation may be variable due to 
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variability in ionisation and ion suppression effects 
62
. With a wide range of columns that are 
available, and developments in LC such as two dimensional LC, ultra high performance LC 
(UPLC), ultra fast LC (UFLC) the application of LC-MS in metabolomics is poised to 
increase.  
 
Gas chromatography is readily available in many laboratories. When coupled to MS it is a 
highly sensitive technique (due to the high sensitivity achieved by the mass spectrometer) and 
gives good results for volatile compounds. Non-volatile compounds can be derivatised and 
GC-MS has the advantage of a bigger established compound library compared to LC-MS. It 





Capillary electrophoresis with mass spectroscopy detection has also been applied to 
metabolomics. Compounds are mainly separated based on the mass to charge ratio and 





1.5.2 Applications of Metabolomics in Toxicity Assessment 
 
The genomics approach for toxicological assessment involves observation of altered gene 
expression after exposure to xenobiotics. The challenge here is that there is no direct 
relationship between gene regulation or expression and the control of cellular systems. This is 
because the majority of DNA is non-coding and protein coding sequences or genes cannot 




. Furthermore there may be some post translational modifications not related to the 
xenobiotic. 
 
The proteomic approach measures production or changes in cellular proteins after exposure to 
xenobiotics or in response to other pathophysiological processes. Generally it involves 
separation and detection or characterisation steps and can therefore be slow and labour 
intensive. Proteomics can give an insight into understanding the mechanism of toxicity and 




Genomics and proteomics are very useful techniques however it is difficult to relate their 
findings to classical indices of toxicity and toxicological end points because they do not 
normally involve measurements of a detailed time-course response to xenobiotics, and the 
measurements are generally not in a multi-organ system 
61
. The metabolomic approach 
investigates in vivo or in vitro systems and it provides real time information on responses due 
to exposure of xenobiotics or other conditions.  
 
Furthermore, certain effects of exposure to xenobiotics may not be related to gene or protein 
alteration but exposure to foreign material may result in a disturbance of the normal fluxes of 
endogenous metabolites in the organism by direct chemical reactions, by binding to key 
enzymes that control metabolism. If the disturbance is significant, it can result into toxic 
effects affecting the whole organism. Abnormal cellular processes in a biosystem are directly 
related to biological fluid composition 
61
, different foreign substances produce characteristic 
changes in the concentrations and patterns of endogenous metabolites in biological fluids, so 




Since the metabolome is close to the phenotype, metabolites profiling provides a better 
representation of the effects of a biochemical process in a biosystem. For this reason, 
“metabolomics” and or “metabonomics” techniques rather than “proteomic” or 
“transcriptomics” techniques were used for investigation of the toxicity of low amounts of 
microcystins in our study. 
 
 
1.5.3 Toxicity of Microcystins 
 





. In vertebrates, toxic effects of microcystins are linked to inhibition of serine-
threonine phosphatases 
69, 70
 which leads to alteration of the cytoskeleton 
70, 71
 in the cells in 
effect destroying the cell structure. 
 







 however in humans, the main concern is chronic exposure to low 
microcystin concentrations 
70
 by direct ingestion through contaminated water or eating 
contaminated seafood or through contact with contaminated water in recreational activities 
such as swimming or work related exposure such as in fishing, leading to dermal exposure 
and inhalation. While several organs like kidney, brain, heart and reproductive organs were 
found to be affected by microcystins 
69, 70
, the liver is the primary target of microcystin 
toxicity. This is because microcystins are large molecules with a partial polar character and 
therefore cannot easily diffuse through the cell membrane. Their transport is facilitated by 
organic anion transport peptides (OATP), mainly expressed in the liver. 
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Recent research suggests that chronic exposure to low amounts of microcystins (2 -20 g/L) 
is deleterious as demonstrated through effects such as alteration of the liver structure and 
protein profiles in zebra fish 
21
 and indication of hepatocellular damage among individuals 
chronically exposed to microcystins 
28
 , in fact chronic exposure has been linked to 
development of primary liver cancer 
69
. Several studies have been carried out in vivo using 
whole animals but due to ethical issues, there is a growing tendency to use cell lines to 
investigate toxic effects in vitro.  
 
Microcystins were found to induce apoptosis in several mammalian cells but hepatocytes 
were severely affected with primary hepatocytes being the most sensitive 
73
. Primary 
hepatocytes usually lose the organic anion transporting peptides during isolation and 
culturing and therefore lose responsiveness to microcystins 
74
, HepG2  (human hepatocellular 
carcinoma) can be used as an alternative because they have been demonstrated to uptake 






   and in addition to their human origin they 
retain several enzymes used in the metabolism of xenobiotics such as cytochrome P450 
oxidases and glutathione-s-transferases. 
 
Microcystins inhibit phosphatases PP1 and PP2A in both acute and chronic exposures 
69
 
however, the effects of microcystins are time and concentration dependent 
70
. Cytoskeletal 
damage, protein hyperphosphorylation, apoptosis and cell blebbing all leading to cell death 
have been reported to occur shortly after exposure to high amounts of microcystins in 
hepatocytes and other cells 
32, 70, 73, 77
. Exposure to high amounts of microcystin inhibits the 
protein phosphatases affecting the cell’s homeostasis by disrupting the functions of PP1 and 
PP2A as well as their protein substrates 
69, 70
. The main pathways regulated by 
phosphorylation and therefore affected by the activities of PP1 and PP2A are affected by 
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regulation of protein activity, examples include: cell signaling, gene expression, DNA repair 
and mitosis 
70
. These pathways are affected through phosphorylation of signaling proteins 
which can result into uncontrolled cell proliferation leading to cancer or apoptosis and cell 
death. Loss of protein kinase activity of DNA-dependent protein kinase (DNA-PK) is 
induced by phosphorylation of proteins and this affects DNA repair. Calcium-calmodulin-
dependent multifunctional protein kinase II (CaMKII) can be activated by Ca
2+
/calmodulin, 
autophosphorylation and limited proteolysis.  Exposure to microcystins activates CaMKII 
and this activation of CaMKII is responsible for regulation of formation of reactive oxygen 
species (ROS) and phosphorylation of proteins. Inhibition of PP1 and PP2A activates 
CaMKII which subsequently initiates apoptosis 
71
. Furthermore, inhibition of PP1 and PP2A 
affects the nuclear phosphoprotein P
53
 which is induced in response to cellular stress and 




Exposure to low amounts of microcystins on the other hand down-regulates the effects of PP1 
and PP2A and leads to an increase in the activity of survival proteins: diacylglycerol (DAG), 
protein kinase C (PKC) and mitogen activated protein kinases (MAPK) of the kinase 
pathway;  and down regulation of death proteins and damaged cells therefore can survive. 
Down regulation of PP1 and PP2A also produces a low amount of ROS. A low amount of 
ROS promotes DNA strand breaks and oxidation of purines and pyrimidines resulting into 









1.5.5 Metabolomics and Metabonomics Approach in the Study of Microcystin Toxicity 
 
The “metabolomic” approach was used to investigate the effect of chronic exposure to 
microcystins. In the case of humans, acute exposure is not common because compared to 
other animals for which may drink algae contaminated water in large quantities, humans can 
be exposed to low amounts by ingesting contaminated water (but they drink less and in cases 
where the algae/toxins are not obvious to the naked eye) or  raw seafood or by exposure 
through swimming or even work related exposure. Therefore, since the exposure is not so 
obvious, there is a risk of unknowingly being exposed to microcystins in large or small 
amounts over a long term leading to chronic exposure. While the amount of toxin may be 
low, continued chronic exposure may be hazardous.  
 
In this study, we investigated the effect of exposure of a human cell line (HepG2) to lower 
concentrations of microcystins in order to understand the effect of chronic exposure to 
microcystins on humans because that is the most probable risk to humans. Besides, a lot of 
research works have been reported for acute exposure in mammals such as rats for whole 
organisms as well as their hepatocytes and there are only a few works about chronic exposure 
and even these focused on proteomic and transcriptomics approaches. 
 
The HepG2 cell line was used because microcystins are liver specific toxins. They are 
relatively large molecules, have a partial hydrophobic character but also exhibit a polar 
character due to the presence of amido and carboxylic groups 
8
 and their transport to the liver 
is facilitated by the bile acid transport system. In the ileum, microcystins are rapidly absorbed 
and transported through the iliac and portal vein to the liver. Hepatocytes are rich in organic 




.  Furthermore, the liver is a target for xenobiotics and chemical or drug induced toxicity 
due to its involvement in active metabolism. HepG2 cells retain activities of various phase 1 
and phase 2 drug metabolising enzymes that participate in activation and detoxification of 
xenobiotics and they have been reported to assimilate microcystin LR 
35
. The HepG2 cell line 
therefore provides a good model for investigation of effect of exposure to microcystins in 
humans due to their human origin and because they retain many of the specialized liver 





















CHAPTER 2 –DEVELOPMENT OF METHODS OF ANALYSIS 
 
 
2.0 Development of CE Methods for the Determination of Cyanotoxins 
 
Capillary electrophoresis is a family of techniques which can be modified to suit separation 
of compounds with different chemistries, the simplest of them CZE can separate compounds 
of different polarities, where analytes are hydrophobic  MEKC can be used and in cases of a 




2.1 CZE and MEKC Methods for Determination of Microcystins LR, RR, YR and 
Nodularin.  
 
In the first phase of method development, capillary zone electrophoresis (CZE) and micellar 
electrokinetic electrochromatography (MEKC) methods were developed for application to 
three microcystins that have similar chemical properties namely: LR, RR and YR and a 
related hepatotoxin nodularin. These microcystins are also the most frequently reported to 













Capillary electrophoresis was performed on a portable CE-P2 system (CE Resources, 
Singapore) equipped with a UV-Vis detector (Shimadzu SPD 10A). Detection was at 238 nm 
(λmax for microcystin).  Fused silica capillaries of 50 m ID (Polymicro technologies) of 65 
cm total length (55 cm effective length) were used and were conditioned by flushing with 
aqueous NaOH (1M) for 30 minutes, followed by deionised water for 30 minutes and finally 
BGE for 30 minutes. In subsequent use the capillary was flushed with NaOH (1M) followed 
by water and BGE for 20 minutes each before commencing experiments each morning, and 
the capillary was rinsed with BGE between runs. The sample was injected hydrodynamically 
at 0.3 psi for 10-15 seconds and voltage applied was  20 to  25 KV or  20 KV for the CZE 
and MEKC modes respectively. Data was acquired and analyzed using Clarity 
chromatography software from Data Apex Clarity (Prague, The Czech Republic). 
 
2.2.2 Chemicals  
 
Cylindrospermopsin, microcystins LA, LF, LR, LW, LY, RR, YR, and nodularin were 
obtained from Alexis biochemicals (Switzerland).Their structures are shown in figure 2.1. 
Formic acid and sodium hydroxide were from Fluka (Singapore). Sodium tetraborate was 
from Merck, cetyltrimethylammonium bromide (CTAB), ethylene glycol, octane and sodium 
dodecyl sulphate (SDS) were from Sigma Aldrich (Singapore). Phosphoric acid was supplied 
by Riedel-de Haen (Germany) and methanol was obtained from Tedia (Tritech Scientific Pte 
Ltd, Singapore). Butan-1-ol used was from Univar.  C18 octadecyl silica (ODS) solid phase 
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extraction (SPE) column, 500 mg (Whatman) and SPE manifold from Supelco (Sigma 
Aldrich- Singapore) were used for sample preparation. 
 
2.2.3 Sample Preparation 
 
Standard solutions of 25-100 µg/mL (25-100 ppm) concentration were prepared by dissolving 
25-100 µg of each individual standard in deionised water (1 mL). For the test samples, known 
amounts of the standard solution were spiked in tap water or reservoir water. This was 
followed by extraction using a C18 (octadecyl silica) SPE column aided by an SPE manifold 
for nodularin and microcystins LR, RR and YR.  
Real water samples (1 litre each) made up of surface water (collected at 4 metres deep in the 
water reservoir) were collected from Kranji water reservoir (Singapore). An aliquot of the 
real sample (50 - 500 mL) was spiked with microcystin standards and extracted. Another 
aliquot of equivalent volume was extracted using the same procedure as the spiked sample 




Figure 2. 1 Structures of cyanotoxins investigated in the study 
52 
 
2.2.4 Selection of Background Electrolyte and Detection Mode 
 
Glycine, N-cyclohexyl-3-aminopropanesulfonic acid (CAPS), phosphoric acid and formic 
acid were investigated as possible background electrolytes for use in CZE separation mode 
using a capacitively coupled contactless conductivity detector (C4D) and a UV detector at the 
wavelength of 238 which is max due to the Adda moiety in microcystins. 
 
2.2.5 Extraction of Nodularin and Microcystins LR, RR and YR 
 
Sometimes the water sample under test may contain other impurities. Furthermore the WHO 
guideline for microcystin in drinking water is 1µg per litre 
4, 16, 79
.  Solid phase extraction can 
be used to remove some interference and to concentrate the sample to an amount that can be 
detected by UV using the methods investigated here. 
 
The SPE column used was activated by 10 ml of HPLC grade methanol (100 %,) followed by 
deionised water (10 mL). The test sample solution was prepared by spiking 5 - 50 μL each of 
the 100 ppm standard solution of microcystins LR, RR, YR and nodularin into 50 - 500 mL 
of tap water or reservoir water sample. This was extracted using C18 SPE column. Finally, the 
test sample was eluted with methanol (5 mL) and concentrated by evaporation in a water 








2.3. Results and discussion 




Test samples were run using a capacitively coupled contactless conductivity detector (C4D) 
and a UV-vis detector to investigate the possibility of use for either detection method. The 
use of C4D detector did not yield satisfactory results as the peaks were not reproducible as 
seen in figure 2.2 below perhaps due to poor sensitivity of the detector used. The use of UV 
detection provided better peak reproducibility and was therefore used in subsequent method 
development. 
 





2.3.1.2 Background Electrolyte (BGE) 
 
CAPS buffer as a BGE resulted in three main peaks for the four analytes. Even though the 
peaks were reproducible, they were broad. Therefore, formic acid (1 M) was investigated as a 
BGE using UV detection. The choice of an acidic BGE was influenced by the properties of 
the analytes. Microcystins LR, RR and YR all have pKa of less than 3.5, so above this pH, 
they will ionise and become positively charged 
8
, if the BGE pH is above 3, the silanol wall 
in the fused silica capillary would be negatively charged. These two factors encourage 
analyte binding onto the capillary wall reducing efficiency of the CZE method for 
quantitation. 
Good separation was obtained and the peaks were reproducible when formic acid (FA) was 
used as a BGE. Therefore, for subsequent separations, formic acid was used as the 
background electrolyte (BGE). 
 
Figure 2. 3 CZE  electropherogram of microcystins LR, RR, YR and nodularin. Analytes were 5 µg /mL 
each; separation was at +25 KV, BGE 1M HCOOH. 
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2.3.2 CZE Separation Conditions 
 
Formic acid (1 M) was used as a BGE in the CZE mode at a voltage of + 25 KV. The 
microcystins were very well resolved. No special pre-treatment or conditioning of the 
capillary was necessary and the hepatotoxins could be detected at low g/mL concentration 
levels. (Figure 2.3 and table 3.) 
 
 
Figure 2. 4. Electropherograms of microcystin RR, nodularin, microcystin YR and microcystin LR.  A) 
CZE - BGE was formic acid (1 M) and voltage was +25 KV. B) MEKC - BGE was made up of formic acid 
(1 M), CTAB (0.1 %) and ethylene glycol (0.1 %). Voltage was - 20 KV. The concentration of each of the 
hepatotoxins was 5 g/mL, UV detection at 238 nm.  
 
 
The elution time in CZE mode was slightly long (~ 17 min) compared to the elution time in 
the MEKC mode. This is in agreement with other research works 
11, 18, 19, 80 
which show that 
the microcystins migrate slowly in acidic pH. The use of formic acid as a BGE was first 
reported by Bateman et al 
80
 in the analysis of microcystin LR. In this study we investigated 
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simultaneous determination and quantification of three related microcystins LR (RMM 
995.17), RR (RMM 1038.2) and YR (RMM 1045.19) and a related hepatotoxin nodularin. 
Phosphoric acid used as a BGE behaved similarly even though the retention time was slightly 
longer and peaks were broader as shown in figure 2.5 A. 
 
 
Figure 2. 5. CZE   Electropherograms obtained using:  A - 50 g/mL each of microcystins RR, YR and 
LR with phosphoric acid (0.1 M), B - 30 g/mL each of the microcystins with formic acid (1 M) as BGE  
 
 
At acidic pH, microcystin RR has two positive charges (from arginine) and therefore will 
migrate towards the cathode faster. Moreover arginine is very hydrophilic and so solubility in 
polar solvents is high. Microcystins LR and YR have a single positive charge but the amino 
acid leucine is more hydrophobic than tyrosine. Therefore YR migrates slightly faster and 
hence they can be separated. Nodularin has a single positive charge as well and migrates 




2.3.3 MEKC Separation 
 
For MEKC, separation was achieved at a voltage of  20 KV. The BGE used was composed 
of formic acid (1 M), cetyl trimethyl ammonium bromide (CTAB) (0.1 %) and ethylene 
glycol (0.1 %). Figure 2.3 B shows the results obtained. The migration order between 
microcystins LR and YR reversed and MEKC gave a very good resolution between the 
analytes (4.3 between RR and nodularin, 7.1 between nodularin and LR; and 10.2, between 
LR and YR) as well as a shorter total run time.  
 
The use of both CZE and MEKC is applicable for confirmation of the results and can be 
useful especially if the peak of the analyte overlaps with that from matrix component 
18
 in 
cases where no sample pre-treatment is done or where sample pre-concentration does not 
include removal of interfering substances. The CZE method and the MEKC method were 
evaluated in their analytical performance and the data is shown in Table 2.1. 
 
2.3.4 Comparison of the CZE and MEKC Methods.  
 
Both techniques offer a good separation. Good resolution (4.3 between RR and nodularin, 7.1 
between nodularin and LR; and 10.2, between LR and YR) and faster migration times were 
obtained using the MEKC technique (refer to table 3 parts A and B). However in both cases 
the resolution obtained is acceptable (18.7 between RR and nodularin, 3.5 between nodularin 







The low volumes injected in CE separations are said to be partly responsible for high 
detection limits. Furthermore in these methods developed the limits of detection (LOD) 
obtained were higher than the recommendations from WHO drinking water guidelines of 
microcystin LR 1 g per litre 1. Therefore pre-concentration techniques were used to improve 
the LOD. 








































Part B. MEKC  
a
                                                            
Microcystin 
RR 
6.13 0.62 1.40 6.44 0.995 
 








9.09 0.85 3.20 2.70 0.997 
 
Part C. CZE of a real sample spiked with RR, YR and LR 
   (µg/L)   
Microcystin 
RR 








21.61 3.31 0.11 9.96  
 
 
 CZE at + 25 KV without stacking     Stacking with the aid of methanol at + 20 KV 
a   MEKC experiments were done at  20 KV, no stacking 
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2.3.4.1 Online Pre-concentration by Sample Stacking. 
 
This technique is usually achieved through by increasing the amount of sample injected. Such 
techniques include large volume injection also known as large volume sample stacking. 
The small sample volumes injected in CE are partly responsible for low sensitivity. Therefore 
a larger volume was injected. Optimum increases in area and height were obtained after 
injection of sample for 60 seconds; however the resolution between the analytes became 
worse with increasing time as shown in figure 2.6. Therefore a trade off was made at 
injection of 40 seconds to take advantage of large volume injection without compromising 
resolution. 
 
Figure 2. 6. Variation of injection time with peak area (A) and peak height (B) 
 
 
 Stacking with the aid of solvents has been reported to improve on the sensitivity. Therefore, 
the attempt to use various solvents: water, methanol and acetone was studied for use as the 
60 
 
solvent in the plug to optimize the stacking efficiency. Injection times (volume) for the 
sample and for solvent were also investigated. Optimum results were obtained by injecting 
methanol in the solvent plug for 5 seconds followed by the sample at 0.3 psi for 40 seconds 
as shown in figure 2.7 which show optimum organic solvent injection below.  
 
 
Figure 2. 7. Investigation of effect of solvent on peak area (A) and peak height (B) 
 
 
Using methanol as an aid during stacking resulted in peak heights for the analytes increasing 
3.9 times for RR, 4.8 times for YR and 2 times for LR in CZE and at least twice in MEKC. 








Table 2. 2 Stacking with the aid of methanol in the CZE mode 
Condition Microcystin RR  
Peak height  (mV) 
Microcystin YR 
Peak height (mV) 
Microcystin LR  
Peak height ( mV) 
Injection of sample 
for 10 s 
0.154 0.031 0.163 
Injection of sample 
for 40 s 
0.411 0.131 0.292 
Injection of 
methanol for 5 
seconds followed by 
sample for 40 s 
0.601 0.149 0.330 












2.3.5.2 Offline Sample Pre-concentration with the Aid of Solid Phase Extraction (SPE) 
 
Off line concentration was achieved with the aid of solid phase extraction. Water samples 
spiked with nodularin and microcystins LR, RR and YR were extracted and eluted as 
described in the experimental section. When a known amount of standard was spiked into a 
known volume of water and extracted, recoveries were 90.3 % (RR), 101.5 % (nodularin), 
90.6 % (YR), and 88.2 % (LR). 
 
The use of SPE enabled cleanup and pre-concentration of a real sample to achieve a 100-fold 
concentration factor. Detection limits after SPE of the real sample spiked with microcystins 
were 0.090 mg/L (RR), 0.076 mg/L (YR), and 0.110 mg/L (LR), with percentage RSD values 
of 9.9 – 11.7 % for peak area and 2.2 – 3.3 % for migration time. This method therefore can 




2.3.6 Tap Water Analysis 
 
Tap water was spiked with microcystins RR, LR and nodularin (5 µg/mL each), and the 
sample was analyzed by CZE with stacking at + 20 KV. The results are shown in the 
electropherogram in figure 2.8 A.  The use of CZE and MEKC is particularly useful for cases 
where no sample cleanup is carried out. This is because the different separation mechanism 
involved can allow for identification of peaks in case of the matrix peak overlapping with the 
microcystin peaks. When sample cleanup is done, either CZE or MEKC can be used as a 




2.3.7 Reservoir Water Sample Analysis  
 
A reservoir water sample (50 mL) was extracted as described in the experimental section and 
eluted with methanol (5 mL). The sample was evaporated in a water bath and the final test 
solution was reconstituted with deionised water (500 µL). To another aliquot of the reservoir 
water sample (50 mL), microcystin standards RR, LR and YR (50 µL each of the 100 µg/mL) 
were added. This sample was also extracted, eluted and reconstituted as the first sample. 
Microcystins LR, RR and YR were not detected in the reservoir water sample. Good 
reproducibility was obtained for the spiked sample as shown in table 3 part c.  Figure 2.8 B 
shows the electropherograms obtained. 
 
Figure 2. 9. CZE of real samples:  A - tap water: (a) spiked with 5 g/mL each of microcystins LR, RR 
and nodularin after stacking with the aid of methanol, (b) tap water that was not spiked. B - reservoir 
water sample (a) spiked with microcystins LR, RR and YR (10 µg/mL each), (b) a repeat run of the 





CHAPTER 3 – DEVELOPMENT OF MEEC 
 
 
3.0 MEEC Principle 
 
In MEEC, separation is based on differences in hydrophobicities of the analytes. Analytes 
partition between the microemulsion (oil) and the mainly aqueous phase in background 
electrolyte. For charged analytes like in this case, additional selectivity due to the 
electrophoretic behaviour of the analytes is achieved. The oil in water emulsion is stabilised 
by a surfactant at a concentration above its critical micellar concentration (cmc) as well as a 
cosurfactant usually a short chain alcohol that reduces electrostatic repulsion between 
surfactant molecules in effect reducing surface tension and stabilising the microemulsion 
81
. 
Figure 3.1 below is a schematic of the MEEC principle of separation. 
 
 





3.1 Development of Microemulsion Electrokinetic Chromatography (MEEC) Method 
for the Determination of Cyanotoxins in Water. 
 
MEEC is a CE technique commonly used for simultaneous separation of both aqueous and 
water insoluble analytes. The presence of oil and a co-surfactant in the MEEC BGE results is 
good selectivity by this method. Hydrophobic analytes can be solubilised 
81
, at the same time 
water soluble components will be solubilised by the aqueous portion of the BGE. This 
technique is therefore particularly useful in simultaneous separation of analytes with a range 
of hydrophobicities. Compared to MEKC, MEEC offers better selectivity for hydrophobic 
compounds because hydrophobic analytes are trapped in the micelle in MEKC and the 
fraction of hydrophobic analytes in the aqueous phase is very low, so they will tend to 
migrate closely, in MEEC on the other hand the amount of hydrophobic analytes in the 
aqueous phase is quite significant 
82
 and the better partition between the oil phase and 
aqueous phase result in better resolution. The analytes under investigation have a range of 
polarities ranging for the polar cylindrospermopsin to more hydrophobic microcystins such as 
LF and LA (based on the amino acids at positions X and Z), therefore MEEC may offer better 
separation.  
 
In the CZE method developed in this study, more hydrophobic microcystins took a long time 
to elute for example microcystin LA did not elute after 40 minutes of CZE separation using 
formic acid as a BGE. When sodium tetraborate was used in CZE, resolution between 
analytes was not good. MEKC resulted in better separation and all the analytes eluted in the 
positive polarity mode, but baseline separation between the late eluting components was not 
achieved, therefore we used MEEC and baseline separation for all the analytes considered in 
this study was achieved. Due to instrument limitations at the time, negative polarity for the 
MEEC mode was not investigated. 
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For MEEC separation a bigger number of hepatotoxins were studied. Cyclic heptapeptides 
(microcystins LA, LF, LR, LW, LY, RR and YR) were separated in the presence of a related 
pentapeptide nodularin and the alkaloid hepatotoxin cylindrospermopsin.  
 
Apart from the regular factors that affect a CE separation such as absorption wavelength used 
for detection, capillary length, background electrolyte concentration and voltage, other 
factors affecting selectivity in MEEC are the type of surfactant and co-surfactant 
48
. 
Selectivity can be changed using non-ionic surfactants or zwitterionic surfactants but the 
most important factor which affects selectivity is the nature of the co-surfactant (low 
molecular weight alcohol) 
48
. Therefore, neutral surfactants and different co-surfactants were 
studied to understand their effects on selectivity. 
 
3.2 MEEC Method Development 
 
3.2 .1 Effect of Absorption Wavelength 
 
The max for microcystins due to the Adda moiety is 238 nm and optimum detection is at 220 
– 250 nm while that of cylindrospermopsin is 260 – 290 nm 11. Cylindrospermopsin and 
Microcystin LA were studied at 230, 238 and 250 nm (refer to figure 3.2)(because the 
absorbance of microcystins beyond 250 nm is weak) to find an optimum in terms of peak 
height and area. The optimum peak height was obtained at 230 nm; therefore, samples were 




Figure 3. 2 Effect of wavelength on peak height 
 
 
3.2.2 Effect of Background Electrolyte Concentration  
 
The effect of BGE concentration was studied for sodium tetra borate in the range 5 - 30 mM. 
Good separation was obtained using 20 mM BGE as shown in the figure 3.3 below. This was 
because at a higher concentration of BGE, the increase in ionic concentration reduces the 
speed of the sample ions leading to longer elution times for the analyte. Considering the 






Figure 3.3 Effect of concentration of the BGE 
 
 
3.2.3 Effect of Surfactant 
 
Neutral surfactants  unlike ionic surfactants can be used in larger quantities without too much 
increase in the electric current and therefore polyethylene glycol was investigated. However 
the analytes co-eluted and the electropherogram was noisy as shown in the figure 3.4. The 
use of cetyltrimethylammonium bromide (CTAB) here was not of any advantage because 
positive polarity was used and in presence of CTAB, the EOF is reversed and thus analytes 
may take a very long time to reach the detector. In this case no peaks were observed after 40 
minutes of analysis. Therefore, sodium dodecyl sulphate (SDS) was used as the surfactant 




Figure 3. 4 Effect of surfactant 
 
 
The effect of percentage SDS was investigated and the electropherograms obtained are as 
shown in figure 3.5.  Increase in the amount of SDS resulted in longer elution times perhaps 
due to increased BGE viscosity and also resulted in increased current due to increased ionic 
concentration. At 3 % SDS composition, peaks were better resolved and the total run time 
was not as long as when 5 % SDS was used. Therefore 3% SDS was used in the BGE 
composition based on favourable current amount and elution time, and in subsequent 
experiments, the BGE was composed of 20mM sodium tetraborate (95 %), SDS (3 %), butan-
1-ol (1.5 %) and octane (0.5 %). Further improvement in peak resolution was achieved by 













Better resolution might have been achieved by increasing the amount of SDS in the mixture 
but this led to an increase in current. Therefore an organic phase (oil) was included in the 
buffer composition. The addition of oil and therefore changing the separation mode form 
micellar electrochromatography (MEKC) to microemulsion electrochromatography (MEEC) 
improved the resolution between the last 2 peaks (8 and 9) (figure 3.7) to achieve baseline 
separation.  
Octane and ethyl acetate were investigated for use as the oil phase. Both gave similar results 
as well as selectivity and the order of elution was the same so either could be used as the oil 
for this separation. 
 
 
3.2.4 Effect of Co-surfactant 
 
Co-surfactants methanol, propan-2-ol, butan-1-ol and acetonitrile were investigated. 
Methanol, propan-2-ol and acetonitrile increased the total run time slightly and for methanol 
some analytes co-eluted. The use of co-surfactant butan-1-ol in the MEEC buffer system 
resulted in good resolution and a shorter analysis time and was therefore used for BGE 
compositions. Results obtained are shown in figure 3.7. A buffer system containing 20 mM 
sodium tetraborate with SDS (3 % or 30 mM), butan -1-ol (1.5 %) and octane (0.5 %) at pH 





Figure 3. 7. Effect of co-surfactant 
 














Cylindrospermopsin 6.332 1.080 2.237 6.306 0.998 
Microcystin LA 7.498 1.317 2.921 3.268 0.983 
Microcystin LY 9.691 2.013 3.056 10.961 0.999 
Microcystin LF 12.555 1.957 4.124 4.952 0.981 
Microcystin LW 13.049 2.605 1.636 7.452 0.929 
Nodularin 13.901 2.284 3.370 4.890 0.982 
Microcystin YR 14.715 2.405 4.242 7.907 0.999 
Microcystin LR 15.266 2.247 3.636 9.600 0.984 









3.3.1 Online Pre-concentration Using a Salt 
 
The use of salt in sample during stacking has been reported to improve sensitivity 
55
, so the 
test samples were dissolved in NaCl at different concentrations in an attempt to improve the 
peak height and sensitivity. As seen from figure 3.8 below, peak heights increased for the 
more polar components in the sample as seen in region (A). While the peak heights increased 
slightly for the hydrophobic components (B), the biggest limitation was degrading resolution 
and peak broadening with salt concentration (visual observation). The method was therefore 
not used. 
 





3.3.2 Online Pre-concentration with the Aid of a Water Plug 
 
An alternative stacking mode is the use of large injection volume stacking. Injection time 
determines the volume of sample introduced in a capillary in hydrodynamic sampling 
41
. Peak 
area increase is normally linear although the increase in peak height may not be linear. While 
increased injection time and therefore increased volume of sample injected leads to an 
increase in peak area and height, separation efficiency reduces with time and in effect the 
resolution between closely eluting peaks declines. This was demonstrated in the use of large 
volume sample injection to optimise sensitivity as shown in the figure 3.9 and table 3.2. 
 
 
Figure 3. 9: Variation of resolution with sample injection time 





Table 3. 2 Performance of the MEE method with large volume stacking 
Analyte 
10 S  Peak 
Area 











of times  
height 
increased 
CYN 0.254 1.125 4.429 0.061 0.243 3.988 
LA 0.444 2.962 6.671 0.147 0.552 3.755 
LF 1.174 4.094 3.487 0.292 0.473 1.619 
LY 0.524 5.071 9.677 0.104 0.366 3.514 
Nod 0.442 5.492 12.425 0.038 0.206 5.414 
LW 0.861 6.705 7.787 0.124 0.364 2.933 
YR 0.603 3.59 5.953 0.083 0.221 2.659 
LR 0.708 5.537 7.821 0.102 0.339 3.326 
RR 0.737 6.798 9.224 0.100 0.452 4.520 


















LOD  3σ 
(ppm) 
CYN 0.545 16.903 10.58 0.930 0.975 0.158 
LA 0.816 8.835 20.09 0.996 0.99 0.422 
LF 1.648 0.932 4.608 0.999 0.971 1.283 
LY 2.029 4.909 11.118 0.992 0.994 0.376 
Nod 2.422 5.513 8.557 0.989 0.999 0.329 
LW 2.317 10.28 6.062 0.904 0.998 0.276 
YR 2.434 13.163 12.773 0.972 0.995 3.095 
LR 2.343 8.826 15.977 0.950 0.999 0.308 
RR 2.232 8.833 2.676 0.994 0.999 0.493 
 
 
Peak areas increased at least 3 times and peak heights increased at least 2.6 times when large 
volumes were injected.  As mentioned previously sample injection for long time results in 
poor resolution, so a short solvent plug was injected before the sample to form a different 
conductivity plug within the capillary and this improved resolution. The highest peak areas 
and heights were achieved with injection of water for 5 seconds followed by the sample 
injection for 80 seconds. The use of other solvents like methanol and acetonitrile in the plug 
resulted in poor resolution for the more hydrophobic late eluting microcystins as 




Figure 3. 10: Stacking using different solvent plugs. 
 
The use of ethyl acetate as the oil in the buffer resulted in better resolution of peaks during 
large volume injection stacking (figure 3.11 and 3.12). Therefore during stacking mode ethyl 
acetate was used instead of octane (figure 3.12). This could be because ethyl acetate has a 
lower surface tension than octane; in fact its use resulted in lower current compared to when 
octane was used. 
 
 





Figure 3. 12:  Electropherogram of the 9 hepatotoxins after large volume injection with stacking. Analytes 
were at 5g per mL, separation was performed at +20 KV. 
 
 
Use of a high conductivity solution in the plug was investigated by injecting 0.1 M HCl for 5 
seconds followed by the sample for 80 seconds. The results were similar to those obtained 
using water in the plug. Resolution of the peaks was better than when NaCl was used for pre-
concentration.  This may be due the fact that in both cases the methods make use of the 










3.4 Real Sample Analysis 
 
Real samples can be analysed after pre-concentration to achieve the 1 g per litre detection 
limit as set by WHO for drinking water guidelines. There are several ways of pre-
concentration such as the use of solid phase extraction (SPE) or other solvent evaporation 
techniques like rotor evaporation and freeze drying. In this method freeze drying was used 
because it applicable to a wide range of analytes, does not compromise the composition and 
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is less tedious. Compared to SPE there is no need for specific sorbents based on different 
polarities of the analytes. 
A real sample of water collected from Kranji reservoir (Singapore) as explained in the 
experimental section in chapter 2, was spiked with microcystin standards at a concentration 
of 2.5 ppm. Samples were freeze dried and reconstituted with deionised water. Another 
sample collected in the same way was also freeze dried and reconstituted with deionised 
water. Test samples were analysed using large volume injection stacking technique. 
Microcystins investigated here were not detected in the reservoir water sample analysed. This 
is as shown in figure 3.14 below. 
 
 




3.5 CZE, MEKC and MEEC Comparison 
 
CZE - The method developed was very simple. The capillary and BGE did not require any 
modification since the separation was at low pH using formic acid as BGE. For those analytes 
which eluted in less than 40 minutes, the resolution between peaks was good (refer to chapter 
2). However, the total analysis time was long and the more hydrophobic microcystins like 
microcystin LA took a long time to elute. 
 
MEKC - This method offered better resolution compared to CZE. When negative polarity 
with reversal of EOF was employed, total analysis time was less than 10 minutes for the 
analytes considered (chapter 2 figure 2.3). In the positive polarity mode, the resolution 
between microcystins RR and LR was not very good even though it was acceptable (figure 
3.7). 
 
MEEC- This technique offered the best resolution for all the 9 analytes studied, however 
analysis time was long (20 minutes) compared to the CZE and MEKC modes. But even then 
it was generally shorter than conventional HPLC techniques which take 20 – 45 minutes 13. It 
is possible to achieve a shorter analysis time by use of reverse polarity but this was not 
investigated due to instrument and time limitation at the time. 
 
Generally the methods developed here achieved detection limits in ranges comparable to 
conventional HPLC-UV methods and together with off line and online pre-concentration 
techniques the LOD improved by at least 10 times. They are applicable for use in a 
concentration range acceptable by WHO drinking water guidelines. Furthermore separation 
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between the different microcystin analogues was achieved using MEEC with higher 
resolution and shorter analysis time compared to conventional HPLC-UV methods. 
 
3.6 CE (CZE, MEKC, MEEC) Compared to HPLC 
 
Methods for determination of microcystins in water have continued to develop. The lowest 
detection limits so far can be achieved using mass spectrometry detection often with LC or 
CE. During our method development we used LC-MS to validate our results obtained using 
CE-UV. Microcystin LR, microcystin RR and microcystin YR were analysed using an 
Agilent 1100 series liquid chromatography equipped with electrospray ionisation source 
(LC/ESI-MS) system (Waldbronn, Germany).  It was made up of a binary gradient pump, 
auto sampler, column oven, diode-array detector and a LCQ-duo ion trap mass spectrometer 
(ThermoFinnigan, San Jose, CA, USA). The LCQ mass spectrometer was operated with the 
capillary temperature at 270 
0
C, sheath gas at 80 (arbitrary units) and auxiliary gas at 20 
(arbitrary units). The electrospray voltage was set at 4.5 kV, the capillary voltage at 10V and 
lens tube offset at 0V. Mass spectra were recorded from m/z 500 –1500. 
 
The mobile phase used was (A) water with formic acid (0.1 %) and (B) acetonitrile with 
formic acid (0.1 %).  A gradient elution starting at 100 % A for 5 min, then 95 % A and 5 % 
B was used. The oven temperature was set at 40 
o
C and the flow rate was 1.5 mL/min. For all 
experiments, volumes of 5 L of standards and samples were injected. The column used for 
the separation was a reversed-phase 3 µm, C18 (100 × 2.0 mm) Luna column. (Phenomenex, 
USA). The ESI-MS spectra were acquired in the positive and negative ion mode. The 
instrument was operated in selected reaction monitoring (SRM) mode. The heated capillary 
temperature was maintained at 350 
0
C, the drying gas and nebulizer nitrogen gas flow rates 
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were 10 L/min and 50 psi, respectively and the number of average scans was 5. The three 
microcystins LR, RR and YR were separated as shown in the chromatogram and spectra 
below (figure 3.15) and the results obtained are as shown in table 3.3. 
 
Figure 3. 15. Spectrum of 20 ppm each of microcystins LR, RR and YR. 
  
 
     
Table 3. 3 LC-MS performance 
Microcystin LOD  µg/L (3σ) 
%RSD intensity 




LR 0.610 6.950 9.589 0.988 
RR 0.3054 3.690 8.547 0.999 




While it was possible to achieve separation in less than 10 minutes using CE (MEKC), the 
earliest eluting analyte in LC was after 10 minutes. The detection limits for HPLC-UV and 
CE-UV were comparable, but MS gave superior results with LOD below the WHO drinking 
water guideline. Separation between microcystins LR and YR was not achieved using LC-
MS but they were identified using SRM. Furthermore, literature reports have shown better 
resolution between microcystin analogues by CE compared to LC and the possibility of a 
faster separation by CE coupled with good resolution was demonstrated in our methods 
developed here. A comparison of CE and LC is shown in table 3.4 below. 
 
Table 3. 4 Summary of a comparison between CE and LC-MS 
Property CE LC-MS 
Total analysis time Faster when reverse polarity is used Generally take longer 
Sensitivity Low, limited by UV detection. Can 
be improved by pre-concentration 
techniques or use of MS for 
detection when the current 
challenges in CE-MS interfaces are 
overcome 
Very sensitive due to MS 
Resolution Higher resolution. All the analytes 
investigated clearly separated 
Resolution was not very 
good. The use of SRM mode 
helped. 
Solvent consumption Low amounts (nanolitre 
consumption) 
Very high (1.5 ml/min for 
every 20 min run time) 
 
 
On this basis, CE separation with MS detection should offer better results in resolution than 
LC-MS. 
 
The analytical methods developed in this study demonstrated a potential for application in 
real samples because there was generally good resolution between microcystin peaks. Real 
samples spiked with standards were analysed and there was no visible matrix interference, 
therefore the results were satisfactory. 
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CHAPTER 4 – METABOLOMICS APPROACH TO INVESTIGATION 
OF MICROCYSTIN TOXICITY 
 
4.0. Development of Metabolomics Approaches for the Investigation of the 
Effect of Exposure of a Human Cell Line to Non Cytotoxic Amounts of 
Microcystins. 
 
“Metabolomic” approaches were used to investigate the effect of exposure of humans to low 
amounts of cyanotoxins.  In humans exposure is usually at low concentrations that are not 
easily visible for example in food or dermal exposure. The purpose of this investigation was 
to determine if exposure to low amounts of microcystins is hazardous and what their effects 
on the metabolome are. A model cell line HepG2 was used in this investigation.  
“metabolomics” was used because the metabolome is more sensitive to perturbations 
compared to the transcriptome or the proteome,  the activities of the different pathways are 
reflected more accurately in the concentrations of the metabolites compared to the 
concentrations of the relevant mRNAs (transcriptome) or enzymes (proteome) involved in the 
pathways; and changes in the metabolome are more amplified in comparison 
83
.   
 
Furthermore, metabolites are usually the same in every organism that contains them thus 
generic techniques can be used in different biosystems. Based on these reasons, the use of 
metabolic profiling should provide superior results compared to proteomics or 
transcriptomics. It is also a cheaper and high throughput technique and that is why this 
technique was used instead of protein profiles or nucleic acid profiles. 
 
In metabolomics, the aim is to profile and quantify all the small molecular weight metabolites 





. This implies profiling all the intracellular and extracellular metabolites. The 
main challenge in measurement of intracellular metabolites is the rapid turnover of 
intracellular metabolites so it requires a rapid quenching technique and it is also time 
consuming 
83, 85
. While intracellular and extracellular metabolites can play different roles 
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metabolites which are secreted, excreted or not taken up by the cells clearly reflect the 
cellular metabolic activity 
83
. Analysis of the medium also referred to as “footprinting” can be 
used to study the metabolic activity of an organism instead of analysing the intracellular 
metabolism because the components in the medium are a reflection of the organism’s 
metabolic activity. Furthermore, the turnover time of metabolites in the medium is not as fast 




In this study, we monitored extracellular metabolites by analysis of the medium and as such 
employed “footprinting” technique as opposed to “fingerprinting” in order to study the 
metabolic activity of HepG2 cells exposed to microcystins, while avoiding errors that may 
result from the failure to achieve rapid quenching, besides it would be easier to analyse a 
biomarker from extracellular fluids like serum or blood instead of from cells or tissue which 














HepG2 Cell line was kindly provided by Professor Hanry Yu of Department of Physiology, 
National University of Singapore. Dulbecco’s modified eagles medium (DMEM) was from 
Invitrogen (Singapore). Fetal bovine serum (FBS) and trypsin - EDTA were from GIBCO 
(Auckland, NZ). Phosphate buffered saline (PBS) was from 1
st
 Base (Singapore). HPLC 
grade chloroform and methanol were obtained from Tedia (Fairfield, OH, USA). CDCl3 was 
obtained from Cambridge Isotope Laboratories Inc. (Andover, MA, USA), D2O with 0.05 % 
(wt) 3-(trimethylsilylpropionic-2, 2, 3, 3,-d4 acid, sodium salt, TSP), propidium iodide (PI) 
and thiazole orange (TO) were from Sigma Aldrich. Deionised water was obtained from a 




Cells were incubated in an InCu saFe® incubator (Sanyo). Flow cytometry was performed on 
a Dako Cytomation Cyan LX and data was acquired and analyzed using Summit software 
version 4.3 from Dako Colorado Inc. A Bruker 500 MHz Ultra shield spectrometer was used 
in 
1
H NMR experiments while an  Agilent 1200 series system equipped with an Agilent 6410 







4.1.3 Cell Culture 
 
HepG2 Cells were cultured in 25 cm
3
 flasks or 6 well plates. Dulbecco’s modified eagles 
medium (DMEM) with 10 % foetal bovine serum (FBS) was used.  The cells were incubated 
in a humidified incubator at 37 
0
C, 5 % CO2.  Whenever cells reached  90 – 100 % 
confluence they were detached and split to be seeded in new flasks. Briefly, the method 
involved washing the cell layer two times using 3 ml of phosphate buffered saline (PBS 1), 
followed by a rinse with 1 mL of trypsin (1). Thereafter the cells were incubated for one 
minute to allow detachment. After all cells detached, they were reconstituted with fresh 
medium and split into the required portions for the next seeding stage. 
 
 
4.1.4 Assessment of the Effect of Microcystins on Cell Viability  
 
Cell viability assessment can be defined as the analysis of living or dead cells.  It portrays the 
morphological, physicochemical and biological differences in the cells. In this study, flow 
cytometry was used to analyse the cells.  Criteria used to characterize viability of cells 
include assessment of the size, shape and refringency of the cells; the ability to incorporate 




For investigation of effects of xenobiotics on cells, the important parameter is the 
determination of the fraction of intact cells 
86
. Analysis of intact cells is commonly done with 
the aid of stains. Exclusion dyes such as trypan blue can be used to stain cells whose 
membrane is compromised. Healthy cells will exclude the dye and the cells can be 
differentiated visually and counted under an optical microscope. Fluorescent dyes such as 
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propidium iodide are also excluded by intact membranes and therefore have a wide 
application in flow cytometry. Vital fluorescent dyes accumulate in metabolically active cells 
and are sensitive to changes in the cell metabolism. Examples include Hoechst 33342 which 
stains DNA and can be used to sort living cells depending on their DNA content. A probe that 
stains all dead and living cells DNA when combined with propidium iodide or ethidium 
bromide for dead cell exclusion can be used for sorting viable cells. The combination of 
exclusion and vital dyes has been used to assess membrane integrity, mitochondrial function 




The purpose of this assessment was to determine the concentration of microcystins that was 
cytotoxic. Therefore different concentrations (0.1 – 1000 ng/mL) of microcystins LR, RR and 
YR were incubated with the cells for 24 hours to determine the lethal concentration for 50 % 
(LC50) of the cells. Since the main objective was to investigate sub lethal toxicity, it was 
necessary to use toxins at concentrations lower than the LC50 for subsequent studies. 
 
After 24 hours, cells were detached and stained using propidium iodide (PI) and thiazole 
orange (TO). The procedure involved detaching the cells by trypsin, followed by addition of 
DMEM (1 mL). The cell solution was then centrifuged and the spent media was poured away 
leaving behind a cell pellet. The cell pellet was re-suspended in phosphate buffered saline 
(PBS). To 500 µL of the cell suspension was added 5 µL of TO (42 µM) followed by 5 µL of 
PI (4.3 mM). The resulting solution was vortexed and analysed using flow cytometry. For 
cell viability assessment, 10,000 cells were considered for each sample.  
 
PI is a DNA stain that works by exclusion i.e. the dye enters the cell only when the integrity 
of the membrane is compromised. Thiazole orange on the other hand stains the entire living 
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DNA in the cell; therefore by comparing the staining patterns by both dyes, live, damaged 
and dead cells can be identified. 
 
 
4.1.5 Sample Preparation 
 
Media (1mL) was extracted using the Bligh-Dyer extraction technique as modified by 
Miccheli et al 
78
. To 1 mL of media, 3 mL of cold methanol: chloroform (2:1), followed by 1 
mL of cold chloroform were added. The mixture was centrifuged at 8000 rpm for 20 minutes 
at 4 
0
C. The supernatant was separated into the aqueous and organic portions which were 
dried by blowing with gentle flow of nitrogen gas or by freeze drying. The dry extracts from 





H NMR Analysis 
 
The aqueous portion was reconstituted with deuterated water (D2O buffered with sodium 
phosphate at pH 7), while the organic portion was reconstituted with deuterated chloroform 
(0.7 mL each), before analysis by 
1
H NMR.  Samples were analyzed on a Bruker ultra shield 
spectrometer to obtain one-dimensional H NMR spectra at an observation frequency of 500 
MHz.   Aqueous samples were analyzed using a pre-saturation pulse sequence (relaxation 
decay 90° acquisition). The water resonance was eliminated by applying a secondary radio 
frequency irradiation during the relaxation delay of 2 s.  Data was acquired at 300 K using 
10330.6 Hz spectral width, into 64 K data points with an acquisition time of 1.586 seconds 
90 
 
and 64 scans. Organic extracts were also analyzed using a single 90
0
 pulse, but with no 




H NMR spectra were manually processed using TOPSPIN software (Bruker Biospin). 
Relative peak intensities were used for quantification and they were identified based on 
literature 
78, 87
. Results were analysed by principal component analysis (PCA) using SIMCA 
P
+
 software. Peak lists were generated using SIMCA P
+
 and they were tested for statistical 




4.1.7 Analysis by Direct Injection Mass Spectrometry (DIMS) 
 
DIMS analysis of all samples were performed on Agilent 1200 series system made up of a 
degasser, binary pump, thermostatic auto-sampler and temperature-controlled column 
compartment. The LC was equipped with an Agilent 6410 triple quad mass spectrometer 
system with an electrospray ionization (ESI) source. The mobile phase used was (A) water 
with 0.1 % formic acid and (B) acetonitrile with 0.1 % formic acid. All samples were run in 
full scan mode in the range 70 – 1000 mass to charge ratio values with an isocratic elution of 







4.1.8 Data Analysis 
 
1
H NMR peaks were picked and normalized using MestReNova software (Mestrelab 
research, Santiago de Compostela, Spain). Aqueous sample peaks were normalised to TSP (at 
a chemical shift of σ  0) while organic sample peaks were normalised to chloroform (at σ  
7. 26). Relative peak intensity data was consolidated in Excel and there after analyzed by 
principal component analysis (PCA) using SIMCA P
+
 software (Umetrics, Umea, Sweden). 
 
MS data was acquired using Agilent Mass Hunter Qualitative Analysis software and then 
extracted into mass spectra in the range of mass-to-charge ratios from 70 to 1000. Relative 
intensities of the peaks were consolidated in Excel and analyzed by PCA using SIMCA P
+
. 
In each case, six biological replicates were used and data was presented as mean  standard 
deviation. To determine which components were significant a list of components was 
generated using SIMCA P
+
 software and they were subjected to a Student t-test and 





4.2.1 Assessment of Cell Viability 
 
At lower concentrations of microcystins, exposed cells did not exhibit morphological 
differences from those that were not exposed to microcystins (as observed under an inverted 
optical microscope). Propidium iodide in combination with thiazole orange was used to 
assess the cytotoxic concentration of microcystins.  Cells incubated for 24 hours in media 
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spiked with microcystins LR, RR and YR (0.1 – 1000 ng/mL) were stained with PI and TO 
and analyzed by flow cytometry. Sample results are as shown in figures 4.1 (PI only) and 4.2 
(PI and TO). 
 
From the results obtained after staining with PI only, it was obvious that the rate of cell 
membrane damage increased with increasing concentration of the toxin. However using only 
PI, only information about membrane integrity can be obtained, thus it is difficult to quantify 
the number of living or dead cells. Thiazole orange was therefore used in combination with 
PI to solve this problem. 
 
The percentage of viable cells (as determined from quadrant R5 in figure 4.2) was plotted 










Figure 4. 1: Flow cytograms obtained using propidium iodide stain. A- Negative control, B- cells exposed 
to 1ng/mL LR, C- cells exposed to 100 ng/ mL LR.  
SSlin represents the side scatter (related to inner cell contents) and FS lin represents the forward scatter (related 















Figure 4. 3: Variation of percentage viable cells with concentration of microcystin in ng per mL 
 
 
For microcystin concentrations in the range 1 – 100 ng/mL, cell death was less than 50% 
even though cell death increased with microcystin concentration and there were no significant 
physical differences in the cell structure. This is in agreement with  literature reports 
3, 24
, and 
this concentration range was used in the investigation of sub lethal toxicity in this research. 
Microcystins were spiked into the growth media (in which cells were cultured) at a 
concentration range 1 – 100 ng/mL. Subsequently 1 mL aliquots of media were withdrawn 
after 6, 24 and 48 hours and they were later extracted and analyzed by 
1








H NMR Results 
 
Figures 4.4 and 4.5 show sample 
1
H NMR spectra of aqueous samples and organic samples 
respectively, obtained in 
1
H NMR analysis. 
 
Figure 4. 4: Sample 
1
H NMR spectra obtained for an aqueous sample. A- full spectra, B – magnification 












4.2.3 MS Results 
 
Figure 4.6 shows sample extracted spectra for aqueous and organic samples obtained from 
direct injection mass spectrometry (DIMS).There were obvious visual differences between 
the aqueous sample extracts and the organic extracts and as expected the positive and 
negative modes also produced different spectra.  
 
Figure 4. 6: Sample extracted mass spectra obtained using DIMS. A- Aqueous sample in positive mode, B- 




4.2.4 Principal Component Analysis (PCA) 
 
Due to the large number of peaks in 
1
H NMR spectra and the large number of mass to charge 
ratio (mZ) values from MS data, the data were compiled in Excel and analyzed using 
principal component analysis (PCA). SIMCA P
+
 software was used to generate PCA plots for 
the purpose of footprinting and a list of components for the purpose of component profiling. 
 
Figures 4.7 and 4.8 A show principal component analysis plots obtained from 
1
H NMR data 
for aqueous samples after exposure to a single microcystin. Negative control samples (black), 
clearly separated from samples exposed to microcystin LR (Blue) and from positive (Red) 
control samples which were exposed to acetaminophen (figure 4.7 A). Samples exposed to 
YR (green) microcystin and RR (pink and purple) did not clearly separate from the negative 
controls but separated from the positive controls as shown in figures 4.7 B and 4.8 A. When 
the data for three microcystins was plotted together, samples exposed to microcystin LR 
(blue) clearly separated from the controls and from those exposed to microcystins RR and YR 
(figure 4.8 B), however, samples exposed to microcystins RR and YR overlapped and did not 
clearly separate from the negative control even though they separated from the positive 
control.  
 
A plot of a mixture of LR, YR and RR together with the individual microcystins showed 
overlaps among samples exposed to microcystins, but the exposed samples clearly separated 
from the negative and positive controls as shown in figure 4.9.  The overlap may be attributed 







Figure 4. 7: PCA plots obtained for single microcystin exposure for aqueous samples analyzed by 
1
H 






Figure 4. 8: PCA plot of 
1
H NMR data for aqueous samples exposed to a single microcystin A- 






Figure 4. 9:  PCA plots obtained from 
1
H NMR data of aqueous samples for microcystins LR, RR, YR 
and mixture with positive control (A) and without positive control (B) 
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Organic samples exposed to microcystins clearly separated from the negative control as 
shown in figure 4.10 A. Figure 4.10 B shows two sets of data obtained when two sets of cells 
were cultured in a mixture (LR, RR and YR). Both separated from the negative control. 
 
Figure 4. 10 PCA plots of organic samples obtained from 
1
H NMR data. A – PCA plot of all the samples 
(LR, RR, YR, mixture) at a similar concentration of 100 ng per mL and negative control. B- Two sets of 




Data points in the clusters obtained from DIMS aqueous data were closer together compared 
to those obtained from 
1
H NMR data. There was good clustering and clear separation of 
samples exposed to microcystins, negative control and positive control (figure 4.11).  
Organic samples also separated from the negative control. Samples exposed to a single 
microcystin (LR, RR or YR) separated from those exposed to a mixture (figure 4.12). This 
could be because the effect of the mixture was more severe than for a single toxin. 
Furthermore mass spectrometry detects compounds at lower concentration than 
1
H NMR; this 
could be the reason why the samples separated better than in the results obtained using 
1
H 
NMR in addition to better clustering achieved using DIMS. Figure 4.13 shows PCA plots 
obtained after DIMS in the negative mode. Visual distinction of the samples was achieved in 















Figure 4. 11: PCA plots obtained from MS data for all aqueous samples of microcystins together with the 






Figure 4. 12:  PCA plots obtained from MS data for all Organic samples of microcystins together with the 






Figure 4. 13: PCA plots obtained for DIMS data from organic samples of microcystins LR, RR, YR, 






Exposure to microcystins has been reported in whole organisms for example exposure of 
Sprague Dawley rats to 500 μg kg−1 MC-LR by i.p. resulted in a loss of cell-to-cell contact, 
shrinkage, rounding, and disassociation of hepatocytes. Exposure has also been reported for 
cells  for example MC-LR at 995.2 ng ml
−1
 induced formation of ROS in primary rat 





 The main target of microcystin toxicity is the liver and the brain has also been reported as a 
target, so microcystins are therefore hepatotoxic and neural toxic. This is attributed to the 
expression of organic anion transporters (OATP for human, Oatp for rat) by the liver and 
brain. Fischer et al 
88
 identified liver specific rat Oatp 1b2 and human OATP 1B1 and OATP 
B3 as mediators of microcystin LR uptake into hepatocytes.  
 
The oral route is the main entrance of microcystins into the human body, microcystins are 
absorbed through the intestines. The majority of absorbed MC-LR (78%–88%) from 
gastrointestinal tract is resorbed by portal blood stream to liver where it penetrates into 
hepatocytes through a multi-specific bile acid transport system in liver. Detoxification of 
microcystins in the liver occurs by conjugation with glutathione via glutathione S-transferase, 
conjugation with cysteine or with oxidized ADDA diene. The three conjugates are excreted 




The toxicity mechanism of microcystin involves inhibition of protein phosphatases 1 and 2A 
(PP1 and PP2A) 
3, 24, 32
. These phosphatases play an important role in the signal transduction 
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pathways by mediating dephosphorylation of proteins. Phosphates regulate the proteins on 
which they are attached, the attachment and removal of phosphate mediated by kinases or 
phosphorylases and phosphatases,   maintains cellular homeostasis 
32
. Protein phosphatases 1 
and 2A help in the maintenance of cellular homeostasis by participating in carbohydrate and 
lipid metabolism, signal transduction, maintenance of cytoskeletal structure, suppression of 
cell transformation and regulation of apoptosis and cell division rates 
32
. Inhibition of PP1 
and PP2 interferes with carbohydrate and lipid metabolism and its effect should be revealed 
by metabolite profiling. 
 
The data resulting from this study shows that there were changes in the relative amounts of 
some components (mainly amino acids, some organic acids and lipids as shown in the 
following section) in the samples exposed to microcystin compared to control samples (refer 
to appendices 1 and 2). This is in agreement with research work by Wang et al 
21
 on zebra 
fish exposed to low amount of microcystin LR. In their study, enzyme amylase, alpha 2A was 
inhibited while pyruvate kinase was prohibited by microcystin LR. This caused a dysfunction 
in carbohydrate metabolism. In our study, beta hydroxybutyrate a ketone body which is 
normally produced during fasting was found to have increased in samples exposed to 
microcystins compared to negative control samples implying disruption of the normal 
glycolysis (appendix 3) pathway. The metabolism of lipids, organic acids and amino acids 
was affected in our study and this is in agreement with research work by Wang et al 
21
 which 
demonstrated perturbation of enzymes involved in lipid metabolism, organic acid metabolism 





4.3.1 Amino acids 
 
Proline, valine, threonine, cysteine, arginine, acetyl aspartate, tyrosine, phenylalanine, 
isoleucine/leucine, asparagine, glutamine, glutamate, histidine, 1-methyl histidine were found 
to increase in samples exposed to microcystins compared to the control samples; while amino 
acids  alanine and serine decreased compared to the control (refer to appendix 4). This 
implies interference in the metabolism of these amino acids. Amino acid metabolism 
generally involves synthesis of nonessential amino acids. Essential amino acids are obtained 
from the diet of the organism. 
 
Essential amino acids valine, threonine, phenylalanine, isoleucine/leucine, histidine 
increased. This implies interference in their catabolic pathways since normally that is the 
mechanism for their reduction. They are obtained from the diet and used to produce other 
biomolecules and in some cases they are used in the synthesis of non essential amino acids.  
 
The main product from valine catabolism is propionyl-CoA, the glucogenic precursor of 
succinyl-CoA.  Threonine is converted into propionyl-CoA through ketobutyrate, isoleucine 
catabolism produces propionyl-CoA and leucine is degraded to produce acetyl-CoA and 
acetoacetate through transamination, decarboxylation and several rearrangements 
89
.  For 
these glucogenic amino acids, increases could be linked to interruption of the tricarboxylic 
acid cycle (TCA) into which the products here should go to in a normal glycolysis process.  
 
Phenylalanine is catabolised by conversion to tyrosine which is later degraded to fumarate 
and acetoacetate. Increase in phenylalanine could be due to interferences in the phenylalanine 
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to tyrosine pathway. Histidine is degraded to produce glutamate and one carbon pool; 
therefore its increase may be due to a dysfunction in the glutamate metabolism pathway.  
 
Nonessential amino acids proline, cysteine, arginine, aspartate, tyrosine, asparagine, 
glutamate and glutamine increased, while alanine and serine decreased.  Proline, glutamine 
and arginine are synthesised from glutamate 
89
 which comes from - ketoglutarate by 
transamination, therefore when the amount of glutamate is high, amino acids proline and 
arginine which are derived from it are also likely to increase. In presence of oxaloacetate, 
glutamate is converted into aspartate by transamination. Asparagine is produced when 
glutamine reacts with aspartate.Aspartate can also be obtained from asparagine by hydrolysis 
as shown in figure 4.14.  
 
Since syntheses of these amino acids are related by the common glutamine, their 
concentration in an organism will be interrelated. Increased production may be due to 
accumulation of - ketoglutarate whose main source is the tricarboxylic acid cycle (TCA) if 
the cycle is interrupted and  - ketoglutarate is not converted to succinyl CoA. TCA cycle is a 
central part of aerobic metabolism as shown in the figure 4.15 below. Its main role is 









Figure 4. 15:  Scheme showing the central role of the TCA cycle in metabolism 
 
 
The TCA cycle produces -ketoglutarate one of the first reactants in amino acid metabolism, 
therefore increase in those amino acids originating from the glutamate metabolism can be 
attributed to interference in the TCA cycle, in fact TCA cycle components like succinate 
were also found to have increased in samples exposed to microcystins. 
 
Glutamine is the most significant nitrogen transporter between tissues and glutamate 
metabolism which is involved in almost all amino acid metabolism is mainly intracellular 
90
. 
In our study, we profiled extracellular metabolites therefore glutamine plays a central role in 
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balance of related amino acids proline, arginine, aspartate, glutamate as mentioned above. 
The Schemes below (figure 4.16) show the synthesis and utilisation of glutamine in the liver. 
Release of glutamine by the liver was reported in animals bearing tumours and this was 
attributed to a decreased glutamine degradation which shifts the balance from an uptake to its 
release. The utilisation or synthesis of glutamine is dependent on the rate of glutamine 










The increase in glutamate and glutamine is in contrast to the study of acute microcystin 
toxicity by Towner et al 
32
 in which they reported a decrease in  the levels of glutamine and 
glutamate. This could be because in their study a higher concentration of microcystin 
(1mg/mL) was used and they investigated acute toxicity compared to our study where the 
highest concentration was 100 ng/mL and we investigated chronic toxicity. An opposing 
response of liver cells to low and high concentration of microcystins was reported by 
Herfindal and Selheim 
71
. This was attributed to the different outcomes that result when 
phosphatases are inhibited by high microcystin dosage or when they are slightly down 
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regulated by low dosage. Low amounts of microcystins cause a slight down regulation of the 
protein phosphatases activity which alters some proteins leading to enhanced survival of 
damaged cells compared to higher amounts which inhibit the phosphatases leading to 
hyperphosphorylation, production of ROS, alteration of the cytoskeleton eventually leading 




Tyrosine is produced by hydroxylation of the essential amino acid phenylalanine in the 
presence of phenylalanine hydroxylase and biopterin cofactor 
89
. The main source of tyrosine 
(phenylalanine) also increased possibly causing its increased production. Tyrosine is 
degraded to produce acetoacetate and fumerate 
89
, in normal metabolism; it should therefore 
be degraded rather than accumulate. An increase signifies interference in its catabolism. 
Wang et al 
21
 reported that microcystin LR  suppressed production of protein  zgc:109929, 
which is a homolog of the fumaryl acetoacetate hydrolase (FAH) domain. FAH is the last 
enzyme of the tyrosine catabolic pathway which catalyzes the hydrolysis of fumaryl- 
acetoacetate into fumarate and acetoacetate. The increase in the amount of tyrosine in our 
study can therefore be attributed to disruption of its catabolic pathway. This would have an 
effect on phenylalanine metabolism too since its main catabolic pathway is production of 
tyrosine and in fact, phenylalanine was also found to increase in samples exposed to 
microcystins compared to controls. The increase in phenylalanine is probably due to end 
product inhibition i.e.  It may no longer break down due to accumulation of tyrosine. 
 
Cysteine is synthesised from the essential amino acid methionine 
89
 by a series of reactions 
converting methionine to homocysteine which then reacts with serine to produce 
cytostathionine which breaks down into cysteine and releases - ketoglutarate.  It can also be 





. Cysteine is degraded to pyruvate by desulfuration but the most 
important catabolic pathway is through oxidation to produce biosynthetic intermediates 
which are later oxidised to produce such compounds as taurine. Cysteine is also used in the 
synthesis of tRNA. Metabolism of cysteine is an integral part of the adenosyltransferase S-
adenosylmethionine (SAM) trans-sulfration pathway to glutathione and taurine (figure 4.17). 
An increase in amount of cysteine could be due to disruption of this pathway or a disruption 
in the catabolism of products here such as taurine. 
 
Taurine is produced from cysteine and is catabolised through the bile acid metabolism 
pathway, hence increased cysteine amounts should result in increased taurine production. In 
our study, the amount of taurine in samples exposed to microcystins was slightly less than in 
the control even though the trends were similar.  
 
 







Serine is produced through the glucose to hydroxypyruvate pathway. It is a precursor to other 
amino acids such as glycine, cysteine and tryptophan as well as sphingolipids and folate. A 
decrease may be due to low reactants, which does not cope with its rate of use and this would 
be the case if the pyruvate pathway is disrupted.  
 
Alanine is synthesised from pyruvate by transamination and hence can be limited by the 
amount of pyruvate (substrate) present, the enzyme or end product inhibition. The implication 
is that interference in production of pyruvate will impact on the amount of alanine produced. 
Chen et al 
28
 established a positive relationship between microcystin concentrations and 
serum enzymes alanine aminotransferase (ALT), aspartate amino transferase (AST) lactate 
dehydrogenase (LDH) and alkaline phospahatase (ALP).  A similar observation for ALT and 
AST was reported by Nishiwaki-Matsushima et al 
72
 and they noted that microcystin LR or 
YR concentration of 50 µg per kg or less did not induce a release of ALT and AST.  
 
An increase in expression of these enzymes is associated with hepatocellular damage and 
tests of these enzyme expressions are commonly used to assess liver function. Since chronic 
exposure to low amount of microcystins led to increased expression of these enzymes, 
microcystin exposure can result in hepatotoxicity leading to liver damage even at low 
concentrations of the toxin.  ALT catalyses the transfer of an amino group from alanine to -
ketoglutarate in the reversible transamination reaction to produce pyruvate and glutamate. 
Glutamate + Pyruvate    ⇌       -ketoglutarate + alanine 
The decrease in alanine in this study can be attributed to interference in substrate (pyruvate) 







4.3.2 Organic acids 
 
The tricarboxylic acid cycle (figure 4.15) plays a central role in organic acid metabolism. 
Malonate, pyruvatoxime, succinic acid, beta hydroxybutrate, amino-tridecanoic acid 
increased, while glyoxylic acid, gylcolate, lactate, glyceric acid, 1-pyrroline-5-carboxylic 
acid and acetoacetate, decreased. The variations in organic acid amounts are shown in 
appendix 5. 
 
Malonate/malonic acid is a well known inhibitor of cellular respiration. It competes with 
succinate for the active cite of succinate dehydrogenase, thereby inhibiting oxidation of 
succinate to fumarate in the tricarboxylic acid (TCA) cycle.  Malonate occurs naturally in 
biological systems and is synthesised from oxaloacetate. It is metabolised to produce malonyl 
CoA in the presence of Malonyl-CoA Synthetase 
93
. 
Malonate + CoA + ATP                                                 Malonyl-CoA + AMP + PPi  
 
Succinic acid is produced from succinyl-CoA in the TCA cycle and converted to fumarate in 
the presence of succinate dehydrogenase. While malonate can inhibit oxidation of succinate 
by competing for succinate dehydrogenase active sites, Wang et al 
21
 found that suclg2 
protein which is responsible for regulating the formation of succinate and ATP from succinly 
– CoA and ADP in the TCA cycle was enhanced by microcystin LR.  Therefore, increase in 
succinate could be attributed to interference of the TCA cycle. 
 
Glycolate and glyoxylate are oxalate precursors. The metabolism of glycolate and glyoxylate 
in HepG2 cells was studied by Baker et al 
94
 and they found that glycolate was taken up more 
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effectively by cells but glyoxylate was more efficiently converted to oxalate. In their study, 
glycolate in the media increased over time and glyoxylate was not detected, perhaps this 
could be because glyoxylate can be converted to glycine and glycolate. In our study both 
decreased. The decrease in glyoxylate in our study can be attributed to its conversion into 
glycolate and conversion into oxalate in the presence of lactate dehydrogenase (LDH). 
Exposure to microcystins has been associated with increased LDH 
28
 which may be 
responsible for increased consumption of glyoxylate. 
 
HepG2 cells rapidly uptake glycolate which is metabolized to produce glycine and the 
concentration of glycolate in the cells and the medium vary lineary 
94
. A decrease as observed 
in our study can be attributed to decreased production perhaps associated with increased LDH 
which converts the reactant glyoxylate into oxalate. 
 
Lactate was found to have decreased in our study. This decrease in lactic acid is in agreement 
with research work by Towner et al 
32




4.3.3 Lipids and Phospholipids 
 
Phosphocreatine, 4-phospho-L-aspartate, inositol 1,3,4-trisphosphate, dihydrosphingosine, 
cytidine diphosphate (CDP), D-myo-inositol 1,4,5-trisphosphate, L-3,5-diiodotyrosine, allyl 
isothiocyanate, , octane, acetylcholine, dodecanamide , amino-tridecanoic acid, linoleic acid, 
decanoyl-L-carnitine,  selenocystine,  inosine 5'-monophosphate (IMP), cholesterol and  25-




Phosphocreatine is synthesised in the liver and transported to the muscle via the creatine 
phosphate shuttle. It is synthesised form amino acids arginine, glycine and methionine (figure 
4.20).  Phosphocreatine undergoes irreversible cyclization and dehydration to form creatinine 
(figure 4.21) 
95
.  The increase in phosphocreatine is consistent with the increase in amino acid 






























AGAT - Arginineglycine amidotransferase
GAMT - S-adenosyl - L- methionine N guanidinoacetate methyltransferase  
Figure 4. 18 Syntheis of creatine 













Figure 4. 19: Relationship between creatine and phosphpcreatine 
http://en.wikipedia.org/wiki/File:Creatine_kinase_rxn.png (Viewed 30 march  2011) 
 
Creatine plays a vital role as phosphocreatine in regenerating adenosine triphosphate in 
skeletal muscle to energize muscle contraction. Creatine is phosphorylated to 
phosphocreatine in muscle in a reaction that is catalyzed by the enzyme creatine kinase. This 
enzyme is at the highest concentration in muscles and nerves.  
 
Dihydrosphingosine (also known as sphinganine) is a blocker of post lysosomal cholesterol 
transport by inhibition of low-density lipoprotein-induced esterification of cholesterol and 
causes unesterified cholesterol to accumulate in perinuclear vesicles. It has been suggested 





Inositol 1, 3, 4-trisphosphate is a specific regulator of cell signalling 
97
. It is a component of 
inositol phosphate metabolism (appendix 7) together with D-myo-Inositol 1, 4, 5-
trisphosphate and inosine 5'-monophosphate (IMP).  Inosine 5'-monophosphate (IMP), is also 
component of alanine and aspartate metabolism 
122 
 
Inositol phosphates play an important role in cellular functions, such as cell growth, 
apoptosis, cell migration, endocytosis, and cell differentiation. Inositol phosphates can be 
produced from glucose 6-phosphate in the presence of inositol-3-phosphate synthase 1 which 
catalyses conversion of to glucose 6-phosphate to1-myo-inositol 1-phosphate 
98, 99
. This is 
later converted to myo-inositol and enters the phosphaditylinositol phosphate metabolic 
pathway. The unphosphorylated inositol ring can be used to produce phosphoinositides 
through phosphatidylinositol phosphate metabolism.  Inositol phosphates can also be 
produced through phosphatidylinositol phosphate metabolism which produces inositol 1, 4, 5 
triphosphate and this joins the inositol phosphate pathway where it is converted to inositol 1, 
3, 4, 5 tetra phosphate. The later can be converted to inositol 1, 3, 4-triphosphate by a kinase 
and a reverse reaction is facilitated by a phosphatase. 
 
Phosphatidylinositol phosphates (also called phosphoinositides) are intracellular signalling 
lipids that regulate several signal transduction processes.  They are important in cellular 
processes such as actin cytoskeletal reorganization, membrane transport, and cell 
proliferation. Phosphoinositides may also affect protein localization, aggregation, and activity 









reported the inhibition of protein phosphatases as well as disruption of the cytoskeletal 
structure of cells by microcystins, in our study, increased production of phosphates in the 





 L-3,5-diiodotyrosine participates in protein synthesis and amino acid biosynthesis, 
selenocystine plays a role in protein synthesis, amino acid biosynthesis and it is a substrate 
for glutathione peroxidase 1. An increase in these components in samples exposed to 
microcystins compared to controls implies interference in protein synthesis due to exposure 
to microcystins. 
 
Acetylcholine and choline are components of glycerophospholipid metabolism (appendix 8) 
and choline also participates in glycine, serine and threonine metabolism. Choline plays a 
physiological role in signalling, neural transmission and participates in the trans sulfuration 
pathway for the synthesis of S-adenosylmethionine (SAM) by providing the necessary methyl 
groups through its intermediate trimethylglycine. Choline was found to have decreased in 
samples exposed to microcystins compared to controls just like serine also a participant in the 
SAM path way, this implies that this pathway is affected by microcystin toxicity. 
 
Decanoyl-L-carnitine plays a role in lipid catabolism, fatty acid transport, energy production 
and linoleic acid is an essential fatty acid while octane is a component of fatty acid 
metabolism. Cholesterol is a component of bile acid biosynthesis as well as a component of 
C21-Steroid hormone metabolism. 25-Azacholesterol is a component of hormones and 
membranes. Increases observed for these compounds suggest interruption in lipid metabolism 







4.3.3.1 Fatty Acid Metabolism 
 
Fatty acids are synthesised in the liver and adipose tissue in the cytoplasm. The main purpose 
of fatty acid synthesis is to produce fatty acids from acetyl-CoA. Acetyl- CoA is transported 
from the mitochondria to the cytoplasm via the citrate shuttle (figure 4.21). 
 
 
Figure 4. 20 Citrate shuttle and fatty acid synthesis 
Taken from http://www.metabolic-database.com/html/citrate_shuttle_animation.html (viewed 




According to Wang et al 
21
, microcystin LR influenced the activities of some enzymes related 
to lipid/fatty acid metabolism and transport namely:  2-hydroxyacyl- CoA lyase 1 and 
zgc:92030 were suppressed by microcystin LR.  2-hydroxyacyl-CoA lyase 1 is a peroxisomal 
enzyme involved in fatty acid -oxidation and thus could influence lipid metabolism.  Zgc: 
92030 contains one acylCoA-binding domain and might be involved in lipid metabolism 
since acyl-CoA-binding proteins participate in acyl-CoA metabolism by binding long-chain 
acyl-CoAs in glycerolipid biosynthesis and in -oxidation.  
 
Diphosphomevalonate decarboxylase was strongly enhanced by microcystin LR 
21
. It is 
responsible in the first committed step in isoprenes biosynthesis and subsequently participates 
in steroid and cholesterol biosynthesis. Its increase will therefore result in increased synthesis 
of steroids and cholesterols. The increase in cholesterols observed in our study can therefore 
be attributed to microcystin toxicity. 
 
Free fatty acid Acyl-coenzyme A
CoASH















Figure 4. 21 Fatty acid degradation 





4.3.4 Purines and Pyrimidines 
 
Cyclic GMP, a component of purine metabolism (appendix 9) decreased and cytidine 
diphosphate (CDP) a component of pyrimidine metabolism increased. GMP is derived from 
guanosine triphosphate and normally catabolised to produce guanine and its decrease 
indicates interference in this pathway. Its role is mainly activation of protein kinases; 
therefore its decrease will lead to decreased phosphorylation of those proteins. CDP is 
converted to cytidine an essential component of RNA. In our study CDP increased implying a 
disruption in its conversion to cytidine for RNA synthesis. These results suggest that 






















In this project, capillary electrophoresis techniques based on capillary zone electrophoresis, 
micellar electrokinetic chromatography and microemulsion electrokinetic chromatography 
were developed for use in determination of cyanotoxins in water. Furthermore, the 
application of metabolomics and metabonomics techniques to investigation of chronic 
microcystin toxicity was demonstrated.  Distinction between samples exposed to 
microcystins and the controls was achieved and the technique of “footprinting” was 




5.1 Quantitative Analysis of Cyanotoxins Using Capillary Electrophoresis (CE) 
 
CE techniques were used for separating and quantifying microcystins, nodularin and 
cylindrospermopsin in drinking water as well as reservoir water samples on a portable 
capillary electrophoresis system. Therefore the ability to use a portable instrument to 
determine cyanotoxins using the methods developed was demonstrated. The technique is very 
simple and can be readily extended to a wider range of microcystins. By using both CZE and 
MEKC the microcystins can be confirmed and pre-concentration enabled detection of the 
microcystins at lower concentrations in accordance with the WHO drinking water guidelines.  
MEEC demonstrated another option of determining a wider range of hepatotoxins. The 
method was applicable to analytes with a wide range of hydrophobicities and in combination 
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with absorbance spectra investigation; it is a powerful technique for determination of 
cyanotoxins. With the inherent advantages of capillary electrophoresis these methods can be 
used in monitoring of presence of microcystins in drinking water for water quality control. 
The main limitation was detection limits that were higher that the WHO drinking water 
guideline of 1 g/ litre. This is due to the short optical path of the detector and attempts were 
made to improve our detection limits through stacking. Stacking together with offline pre-
concentration by freeze drying or solid phase extraction enabled us to achieve detection limits 
acceptable according the WHO drinking water guidelines.  
 
In the MEEC method, only positive polarity was used due to instrument limitation, the total 
analysis time in MEEC can be shortened by reversing the EOF with additives such as CTAB 
and use of negative polarity. Based on results obtained for MEKC, it is possible to achieve 
separation of the microcystins studied in a shorter time by the MEEC method. In future 
negative polarity can be used for the MEEC method to shorten the analysis time.  
Furthermore, other detection methods can be investigated for example using laser induced 
fluorescence detection may improve detection limits, online derivitazation can also be studied 
and the method can be applied to other cyanotoxins that lack strongly absorbing 
chromophores like saxitoxins. 
 
5.2 Evaluation of Effects of Chronic Exposure of a Human cell Line to Microcystins  
 
From this study, microcystins in concentrations lower than acute concentrations were found 
to have an effect on the metabolism of HepG2 cells as seen from the results of analysis of 
their metabolic finger/foot prints. Using the metabolomics approach, we demonstrated that 
exposure to microcystins even at non cytotoxic concentrations disrupts carbohydrate 
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metabolism, amino acid metabolism, the tricarboxylic acid cycle and fatty acid metabolism. 
Furthermore nucleic acid metabolism was also affected. In summary, exposure of HepG2 
cells to non cytotoxic amounts of microcystins resulted in the following effects: 
 
Hepatic glutamine and glutamate metabolism which is an integral part in amino acid 
metabolism was disrupted. As a result, the quantities of proline, arginine, asparagine and 
aspartate were also affected. Tyrosine catabolism was disrupted and this had an effect on 
phenylalanine amounts too. Microcystins affected the transulfuration pathway, the pyruvate 
pathway as well as protein synthesis. Pyrimidine and purine metabolism were affected as 
seen from a decrease in GMP and increased CDP. Therefore microcystins interfere in the 
synthesis of nucleic acids. The decrease on glycolate can be attributed to increased LDH 
which is often associated with exposure to microcystins. The later are also associated with 
inhibition of phosphatases and the increase in inositol phosphates observed in this study is in 
agreement with inhibition of phosphatases. 
 
Furthermore we demonstrated that footprinting is very useful for distinguishing samples 
exposed to microcystins and those that were not exposed.  By profiling the components in the 
media after exposure to microcystins, there were clear distinctions between samples exposed 
to microcystins, those exposed to acetaminophen (positive control) and control (negative 
control) samples. The metabolomic methods used here therefore were able to distinguish and 
to classify samples according to compound which they were exposed to. While it was not 
possible to differentiate between samples exposed to a specific microcystin, samples exposed 
to a single microcystin clearly separated from the control as well as from a mixture. This is 
attributed to the similar characteristics of microcystins LR, RR and YR which have similar 
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properties and undergo the same detoxification mechanism in the liver via formation of a 
glutathione complex. 
 
Samples exposed to a mixture of the three microcystins at 100 ng per mL separated from 
those exposed to individual microcystins as well as those exposed to the mixture at a lower 
concentration of 1 – 10 ng/mL. This could be attributed to more severe effects of the mixture 
at a higher concentration (higher total concentration) compared to when the cells were 
exposed to a single microcystin or when the mixture was at a lower concentration. 
 
It was observed that cells exposed to the microcystins at low concentrations in this study did 
not die rather they continually proliferated and were observed to have increased in number 
compared to the negative control cells (based on observation under a microscope) which 
could indicate a non controlled growth that can result into tumours. Therefore another type of 
cell could be investigated to confirm whether the proliferation was due to the cancerous 
nature of the HepG2 cell line or otherwise. 
 
 
5.3 Future Work 
 
In future, the mechanisms by which microcystins interfere with metabolic pathways can be 
investigated. For example, the enzymes that are affected by microcystin exposure can be 
investigated further to understand how exactly microcystins interfere with amino acid 
metabolism. Such studies could be applicable in search for an antidote for microcystin 
poisoning for example using compounds that compete with microcystins in their mechanism 
yet not as toxic. Understanding of the pathways and mechanisms involved can contribute to 
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understanding dose – response relationships and differential species sensitivity. Furthermore, 
understanding the mode of action can be applicable in risk assessments and provide a basis 




Furthermore the metabolomics approach can be applied to study effects of exposure to other 
algal toxins such as cylindrospermopsin, saxitoxins and the lipopolysaccharides. This would 
help in identifying biomarkers of exposure to the different classes of toxins and 
understanding their mechanisms of action.  
 
This metabolic approach can be used in combination with other omic approaches in further 
investigations, because the integration would help not only to understand the effects of 
exposure, but also be used to predict deleterious effects which are meaningful to risk 
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Appendix 4 Amino acid Variation 
Table 5. 1 Table showing Variation of Amino Acids (MS data) at 6 Hours 
Amino acid mZ 6H Neg AV  6H Mix 1 ng AV  6H mix 10 ngAV  6H Mix 100 ng AV 
Alanine 90.1 11.702   0.93 8.017  0.83 7.445  0.78 7.67  0.88 
Serine 106 190.723   8.83 170.682  4.46 165.89  3.049 162.58  2.19 
Hypotaurine 110 573.572  53.74 2248.767  264.64 1699.33  111.29 1419.843  71.33 
Creatinine 114.1 200.09  1.99 173.05  4.66 173.163  5.41 167.993  3.27 
Proline 116.1 131.048  6.82 117.987  5.52 119.288  4.7 113.073  5.36 
Valine 118.1 341.752  7.68 360.738  4.64 373.15  6.93 366.763  8.61 
Threonine 120.1 337.587 17.41 335.562  31.68 332.273  2.64 322.097  20.14 
Cystein 122 512.222  13.69 517.545  12.85 527.297  15.1 503.203  7.88 
Taurine 126 32.938   1.73 37.738  1.08 36.287 3.71 36.557  1.36 
Creatine 132 579.288  19.97 455.512  9.26 468.452 10.76 444.682  10.81 
Isoleucine, leucine 132.1 509.215  19.52 404.21  12.05 416.815  9.69 395.372  10.44 
Asparagine 133.1 124.375  2.53 111.638  1.49 115.645  3.58 109.058  3.91 
Glutamine, 147.1 123.662  6.85 141.773  4.47 138.378  3.93 140.63  9.67 
Glutamate 148.1 37.535  2.97 43.187  3.39 43.305  2.69 42.423  2.76 
Methionine 150.1 368.505  5.19 375.865  9.18 384.943  3.54 381.357  4.42 
Histidine 156.1 360.45  10.97 228.633  10.8 218.237  5.71 206.52  13.54 
Phenylalanine 166.1 109.72  5.79 126.628  7.39 130.09  3.98 125.807  8.16 
1-Methyl Histidine 170.1 120.792  4.39 150.778  2.96 155.775  4.19 152.108  4.17 
Arginine 175.1 840.265  54.71 952.49  107.55 963.023  13.1 837.93  40.35 
Acetyl  aspartate 176.1 285.388  14.89 286.463  21.05 307.678  7.92 279.763  13.43 
Tyrosine 182.1 59.675  1.72 64.888  3.09 64.452  2.28 65.798 3.74 




   
Table 5. 2 Table showing Variations of Amino Acids (MS data) at 24 Hours 
  m/Z 24 H Neg CtL AV 24 H Mix 1 ng AV 24 H Mix 10 ng AV 
24 H Mix 100 ng 
AV 
Alanine 90.1 9.978  1.08 7.868  1.11 7.703  0.7 7.504  0.68 
Serine 106 173.382  4.28 160.812 2.74 165.073  2.11 162.515 4.11 
Hypotaurine 110 477.123  19.33 1233.268  40.49 1119.655  34.49 985.733  33.2 
Creatinine 114.1 205.818  5.44 176.415  2.78 174.907  4.15 182.433 11.8 
Proline 116.1 128.375 3.91 118.0717  4.55 124.7  4.61 120.538  5.78 
Valine 118.1 358.957  10.7 372.35  4.39 376.785  4.6 386.372  21.13 
Threonine 120.1 335.09  6.88 334.897  12.64 347.007  16.12 333.293  33.71 
Cystein 122 566.762  10.49 545.212  7.05 542.805  5.06 550.707  24.48 
Taurine 126 34.087  2.47 36.523  1.85 38.588  2.79 38.181  2.04 
Creatine 132 557.157  8.92 453.775  6.38 464.54  9.97 461.021  20.76 
Isoleucine, leucine 132.1 486.562 11.17 405.98  4.43 416.348  12.18 412.962  20.94 
Asparagine 133.1 126.17  4.4 113.577  6.32 118.773  2.31 118.179  5.8 
Glutamine, 147.1 123.245  1.79 146.142  9.18 148.155  4.93 154.307  9.15 
Glutamate 148.1 41.193  2.21 46.047  3.8 44.557  2.42 45.465  3.54 
Methionine 150.1 371.497  14.26 379.025  5.19 381.702  2.73 382.927  5.11 
Histidine 156.1 344.535  12.74 204.832  2.84 202.303  6.48 205.128  13.99 
Phenylalanine 166.1 116.728  3.84 130.492  4.77 137.213  5.97 136.199  7.69 
1-Methyl Histidine 170.1 133.225  4.08 164.8  4.37 167.342  5.24 167.604  9.97 
Arginine 175.1 868.903  27.89 877.563  33.57 900.06  25.93 813.123  103.93 
Acetyl  aspartate 176.1 308.738  5.028 287.115  7.14 293.0517  9.54 277.365  17.48 






Table 5. 3 Table Showing Variation of Amino Acids (MS data) at 48 Hours 
  m/Z 48 H Neg CtL AV 48 H Mix 1 ng AV 48 H Mix 10 ng AV 
48 H Mix 100 ng 
AV 
Alanine 90.1 10.788  1.17 6.376  1.34 6.71  1.18 7.83  1.68 
Serine 106 170.352  3.95 140.946  7.02 140.042  6.63 162.798  8.53 
Hypotaurine 110 425.943  17.89 882.779  24.79 872.985  31.09 893.115  38.2 
Creatinine 114.1 224.858  7.0  260.77 10.64 253.067 12.97 207.158  7.92 
Proline 116.1 127.977  3.38 262.994  5.58 263.085  11.92 133.245  35.67 
Valine 118.1 377.282  9.07 662.387  15.23 665.223  10.46 433.758  66.6 
Threonine 120.1 318.323  18.17 953.723  59.53 945.517  85.44 399.836  186.39 
Cystein 122 601.423  10.78 848.981  41.17 831.108  40.75 611.501  79.64 
Taurine 126 36.023  3.13 54.973  4.16 50.683  4.95 39.218  1.68 
Creatine 132 521.477  13.32 760.201  30.24 755.062  41.97 502.533  76.85 
Isoleucine, leucine 132.1 454.478  10.72 749.089  27.19 742.313  41.56 459.006  81.99 
Asparagine 133.1 129.402 2.78 197.316  16.63 197.323  14.19 134.343  20.15 
Glutamine, 147.1 112.622  5.19 362.336  18.54 363.753  12.3 172.93  42.29  
Glutamate 148.1 43.303  2.96 78.971  7.73 76.555  7.69 52.015  9.98 
Methionine 150.1 381.33  11.2 345.517  15.36 356.972  9.89 392.513  19.66 
Histidine 156.1 317.888  17.24 408.301  14.75 416.823  14.69 225.543  45.99 
Phenylalanine 166.1 120.095  4.82 317.281  23.13 330.702  17.47 156.714  54.51 
1-Methyl Histidine 170.1 136.182  5.43 382.441  26.86 370.553  25.64 188.864  38.92 
Arginine 175.1 693.678  32.23 2392.936  97.16 2402.477  137.49 811.944  542.71 
Acetyl  aspartate 176.1 249.303  4.62 795.153  38.83 819.173  42.98 282.51  172.05 





       Appendix 5 Organic acids Table of Results 
     Table 5. 4 Relative Intensities of Organic acids (MS Data) 
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Appendix 6 Lipids Sample Results 
Table 5. 5 Relative Intensities of Lipids and Phospholipids (MS Data) at 6 Hours 
   m/Z 6H Neg AV 6H Mix 1 ng AV 6H mix 10 ngAV 6H Mix 100 ng AV 
allyl isothiocyanate 100 228.743 ± 7.24 234.257 ± 4.40 222.187 ± 7.07 219.647 ± 5.35 
Choline 104.1 653.193 ± 33.27 583.443 ± 14.52 616.752 ± 13.79 569.005 ± 18.00 
Octane 115.2 26.785 ± 2.47 22.777 ± 1.59 22.412 ± 1.02 20.918 ± 0.38 
Acetylcholine 146.1 41.150 ± 3.99 54.695 ± 3.48 56.027 ± 4.84 53.82 ± 1.96 
dodecanamide 200.3 42.720 ± 2.44 50.768 ± 1.82 53.445 ± 2.44 49.827 ± 1.71 
Phosphpcreatine 212 33.630 ± 1.94 36.743 ± 2.39 35.472 ± 1.79 34.835 ± 2.25 
4-Phospho-L-aspartate 214 42.502 ± 3.17 63.075 ± 3.39 65.032 ± 4.06 63.133 ± 2.85 
amino-tridecanoic acid 230.3 24.427 ± 3.03 39.777 ± 2.23 41.642 ± 1.84 43.188 ± 2.57 
Linoleic acid 281.3 77.063 ± 2.92 67.548 ± 4.58 64.910 ± 1.49 62.620 ± 1.51 
Dihydrosphingosine 302.4 290.238 ± 10.37 338.192 ± 9.18 331.063 ± 9.22 331.358 ± 6.90 
Decanoyl-L-carnitine 316.4 169.287 ± 8.45 117.547 ± 3.47 112.620 ± 4.48 110.545 ± 2.30 
Selenocystine 324.8 38.812 ± 3.85 36.823 ± 1.52 36.238 ± 1.83 34.602 ± 1.36 
Cyclic GMP 345.9 96.888 ± 3.26 84.328 ± 7.045 82.788 ± 4.66 81.148 ± 3.58 
Inosine 5'-monophosphate (IMP) 348.9 56.803 ± 4.36 49.840 ± 3.32 50.073 ± 3.27 48.133 ± 3.282 
Inosine 5'-monophosphate (IMP) 349 63.258 ± 4.45 54.682 ± 3.65 53.702 ± 3.59 53.08 ± 3.53 
Cholesterol 387.4 22.822 ± 2.22 24.092 ± 2.95 22.077 ± 3.05 22.547 ± 5.04 
25-Azacholesterol 388.5 19.488 ± 1.98 18.407 ± 1.79 18.117 ± 3.05 17.152 ± 1.16 
Cytidine diphosphate (CDP) 403.9 86.193 ± 2.65 94.715 ± 4.43 94.957 ± 3.42 93.123 ± 6.15 
D-myo-Inositol 1,4,5-
trisphosphate 420.8 55.102 ± 2.42 52.897 ± 3.14 54.430 ± 3.49 53.57 ± 1.39 
Inositol 1,3,4-trisphosphate 420.9 68.173 ± 3.195 65.177 ± 3.48 64.092 ± 3.65 64.433 ± 1.20 
L-3,5-Diiodotyrosine 433.7 28.00 ± 2.34 28.943 ± 2.29 32.345 ± 2.75 28.69 ± 2.40 
L-3,5-Diiodotyrosine 433.8 37.220 ± 3.61 38.195 ± 2.59 42.407 ± 3.98 38.135 ± 2.58 
L-3,5-Diiodotyrosine 433.9 46.107 ± 4.19 46.353 ± 3.43 51.163 ± 4.72 46.055 ± 3.53 
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Table 5. 6 Relative Intensities of Lipids and Phospholipids at 24 Hours 
  m/Z 24 H Neg CtL  24 H Mix 1 ng  24 H Mix 10 ng  24 H Mix 100 ng  
allyl isothiocyanate 100 224.695 ± 5.33 221.632 ± 5.60 225.515 ± 4.60 223.078 ± 6.58 
Choline 104.1 638.362 ± 12.66 585.78 ± 15.47 596.487 ± 14.33 559.412 ± 26.09 
Octane 115.2 25.538 ± 1.21 22.688 ± 2.71 24.713 ± 1.66 24.464 ± 1.58 
Acetylcholine 146.1 51.862 ± 4.42 58.117 ± 4.88 62.907 ± 2.20 62.856 ± 6.94 
dodecanamide 200.3 53.85 ± 4.35 52.047 ± 3.41 52.163 ± 2.79 52.564 ± 4.23 
Phosphpcreatine 212 28.042 ± 2.06 33.973 ± 1.91 33.415 ± 2.27 31.868 ± 2.22 
4-Phospho-L-aspartate 214 48.422 ± 3.38 65.098 ± 2.70 68.572 ± 3.23 65.371 ± 4.32 
amino-tridecanoic acid 230.3 28.690 ± 3.01 44.503 ± 3.06 45.813 ± 3.52 47.736 ± 3.45 
Linoleic acid 281.3 72.492 ± 3.80 66.22 ± 3.40 66.767 ± 5.33 63.916 ± 3.46 
Dihydrosphingosine 302.4 259.913 ± 5.75  330.267 ± 4.70 327.905 ± 7.09 321.397 ± 8.25 
Decanoyl-L-carnitine 316.4 150.197 ± 5.80 107.368 ± 3.78 109.247 ± 5.87 101.296 ± 9.25 
Selenocystine 324.8 34.775 ± 2.02 34.918 ± 2.18 34.438 ± 1.23 33.108 ± 1.58 
Cyclic GMP 345.9 102.450 ± 3.60 80.812 ± 4.50 81.163 ± 3.39 80.162 ± 5.81 
Inosine 5'-monophosphate (IMP) 348.9 55.363 ± 2.19 49.01 ± 4.34 46.927 ± 1.52 45.336 ± 3.88 
Inosine 5'-monophosphate (IMP) 349 58.727 ± 2.25 54.367 ± 5.53 51.565 ± 2.27 49.067 ± 4.42 
Cholesterol 387.4 19.792 ± 2.67 23.137 ± 4.21 20.548 ± 2.59 19.268 ± 5.31 
25-Azacholesterol 388.5 20.083 ± 1.02 17.173 ± 0.92 18.32 ± 1.73 16.288 ± 1.23 
Cytidine diphosphate (CDP) 403.9 91.138 ± 4.89 89.612 ± 2.01 92.525 ± 4.43 94.0792 ± 8.09 
D-myo-Inositol 1,4,5-
trisphosphate 420.8 53.832 ± 3.34 54.09 ± 2.94 54.427 ± 4.43 54.053 ± 2.86 
Inositol 1,3,4-trisphosphate 420.9 66.457 ± 3.90 64.387 ± 4.27 64.228 ± 4.59 64.623 ± 3.12 
L-3,5-Diiodotyrosine 433.7 31.092 ± 2.23 28.662 ± 3.20 30.795 ± 2.26 29.502 ± 4.17 
L-3,5-Diiodotyrosine 433.8 42.188 ± 2.01 38.583 ± 4.24 41.675 ± 3.58 39.607 ± 5.52 





        
Table 5. 7 Relative Intensities of Lipids and Phospholipids at 48 Hours 
  m/Z 48 H Neg CtL  48 H Mix 1 ng  48 H Mix 10 ng  48 H Mix 100 ng  
allyl isothiocyanate 100 229.648 ± 4.70 232.811 ± 7.43 234.042 ± 6.04 228.961 ± 6.83 
Choline 104.1 507.815 ± 11.46 977.763 ± 46.16 968.800 ± 43.41 575.128 ± 132.63 
Octane 115.2 29.357 ± 3.34 48.76 ± 3.537 47.510 ± 7.50 28.672 ± 3.39 
Acetylcholine 146.1 62.405 ± 3.23 148.224 ± 5.58 143.003 ± 9.23 80.924 ± 8.07 
dodecanamide 200.3 51.502 ± 2.69 121.29 ± 9.40 117.515 ± 9.32 57.703 ± 9.76 
Phosphpcreatine 212 30.987 ± 2.15 43.517 ± 3.67 44.850 ± 3.90 31.119 ± 2.37 
4-Phospho-L-aspartate 214 56.805 ± 3.33 114.999 ± 5.45 116.785 ± 5.51 72.518 ± 9.52 
amino-tridecanoic acid 230.3 33.7633 ± 1.63 62.367 ± 5.11 56.015 ± 8.61 47.591 ± 2.10 
Linoleic acid 281.3 71.468 ± 2.96 96.019 ± 10.21 92.142 ± 8.12 69.368 ± 6.28 
Dihydrosphingosine 302.4 298.712 ± 14.09 410.924 ± 29.90 402.317 ± 38.81 327.847 ± 21.89 
Decanoyl-L-carnitine 316.4 146.368 ± 8.56 151.757 ± 31.22 137.762 ± 21.70 107.352 ± 10.59 
Selenocystine 324.8 36.692 ± 1.62 43.34 ± 2.64 40.768 ± 2.87 35.255 ± 3.59 
Cyclic GMP 345.9 103.975 ± 4.09 68.263 ± 5.94 68.08 ± 4.88 82.737 ± 6.32 
Inosine 5'-monophosphate (IMP) 348.9 56.518 ± 1.84 77.096 ± 7.05 71.365 ± 8.92 47.893 ± 9.60 
Inosine 5'-monophosphate (IMP) 349 60.837 ± 1.90 85.646 ± 8.88 78.823 ± 8.96 51.914 ± 11.11 
Cholesterol 387.4 24.455 ± 1.92 63.076 ± 15.85 52.265 ± 10.75 28.300 ± 18.85 
25-Azacholesterol 388.5 23.555 ± 1.92 21.177 ± 2.96 23.217 ± 3.18 18.723 ± 2.40 
Cytidine diphosphate (CDP) 403.9 94.615 ± 1.67 274.567 ± 6.73 279.537 ± 11.23 115.707 ± 55.87 
D-myo-Inositol 1,4,5-
trisphosphate 420.8 57.560 ± 3.49 85.593 ± 3.72 84.445 ± 5.27 60.073 ± 15.61 
Inositol 1,3,4-trisphosphate 420.9 68.400 ± 3.11 96.52 ± 5.83 96.755 ± 5.72 69.553 ± 15.12 
L-3,5-Diiodotyrosine 433.7 30.660 ± 1.70 66.724 ± 5.49 67.095 ± 6.05 35.465 ± 12.47 
L-3,5-Diiodotyrosine 433.8 40.972 ± 2.40 94.917 ± 7.53 93.142 ± 6.18 48.768 ± 17.90 














Appendix 9 Pyrimidine Metabolism 
 
